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1. Introduction 
Nuclear medicine supplies with functional perspective in the diagnosis of different 
pathologies of the musculoskeletal system. Bone scintigraphy is one of the most used 
nuclear medicine techniques in our clinical practice for location, evaluation and diagnosis of 
these pathologies because of its high sensitivity. This technique identifies functional changes 
before structural lesions have been established. For the study of musculoskeletal disorders, 
the usage of three-phase bone scintigraphy is applied more often than conventional bone 
scintigraphy. However, due to its low specificity, it has been replaced by other techniques 
such as magnetic resonance imaging (MRI) in the evaluation of localized lesions. New 
techniques in nuclear medicine which provide precision with high sensitivity are currently 
available, such as single-photon emission computed tomography (SPECT), useful in the 
evaluation of lumbar and hip pathology, or the presence of inflammation in small joints 
(hands and feet), and positron emission tomography (PET), which provides a metabolic 
imaging. Several radionuclides can be used in the scintigraphic evaluation, although the 
most commonly used for bone scintigraphy are labelled with technetium 99-m (99mTc), 
standing out diphosphonate compounds such as methylene diphosphonate (MDP). This 
radiopharmaceutical (Tc-99m-MDP) is used for studying metabolic bone diseases like 
Paget´s disease, transient osteoporosis and reflex sympathetic dystrophy. And it is also 
useful in the location of polytopic forms of avascular osteonecrosis, in the study of hidden 
painful radiologic bone lesions such as osteoid osteoma or others bone tumours, in the 
evaluation of soft-tissue lesions, and in the assessment of spread pattern of bone metastases. 
Furthermore, this radionuclide may locate bone fractures, identify the cause of pain in 
patients with chronic pain after arthroplasty, show the evolution of heterotopic ossification 
and provide information about musculoskeletal system infections (in combination with 
other radionuclides) and paediatric diseases. Other radionuclides commonly used in the 
evaluation of infectious or inflammatory processes in the musculoskeletal system are 
gallium citrate and indium 111-labelled leukocytes, since the latter increases the specificity 
of technetium radiotracer. Local treatments can be applied by radio isotopic techniques. One 
of these is radiosynoviorthesis, used in the treatment of patients with persistent 
monoarthritis in different stages (from inflammatory poliarthritis to pigmentary 
villonodular sinovitis).  
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The objective of this chapter is to make a simple but detailed review of the main nuclear 
medicine clinical applications in the appraisal and management of musculoskeletal problems.  
2. Normal bone scintigraphy 
Bone scan is a diagnostic technique used to assess the presence of anomalies in the 
distribution pattern of bone formation. It has high sensitivity, but specificity is frequently 
variable or limited. Three-phase bone scintigraphy is currently the most used technique 
because it allows evaluating the degree of hyperemia (flow phase), increased of articular 
permeability (blood pool phase) and the presence of alterations in bone remodeling (bone 
tissue phase). Traditional technique is based on the biological properties of bisphosphonates 
marked with 99mTc, usually MDP, when they are integrated into the bone metabolism after 
intravenous administration. Typically, 30% of the injected dose of Tc-99m-MDP remains in 
the skeleton, and most of bone uptake occurs in the first hour. The remainder is eliminated 
from the tissues and blood by the kidneys and imaging is obtained 3 – 4 hours later. In 
general, uptake of the tracer depends on local blood flow, osteoblastic activity and 
extraction efficiency. Normal scintigraphy imaging depends on technical equipment and 
employees, but it is also significantly influenced by other factors such as age and 
constitution of the patient, intake of drugs, degree of hydration, renal function and/or the 
presence of impaired circulation. Therefore a whole body study is recommended, with 
anterior and posterior screenings that allows assessing the symmetry or asymmetry in the 
distribution of the drug. However, a located study may be sufficient in some cases, since 
provides greater image quality and requires less time and is less expensive. In other 
patients, especially when a spine study is necessary or avascular osteonecrosis located in the 
hip or knee is suspected, it will require a SPECT, that is more sensitive for detecting 
abnormalities and provides, combined with tomography, three-dimensional images. 
It is necessary to have knowledge of normal variants and patterns of abnormality to 
minimize misinterpretation. Whole body bone scan shows normal variations in the uptake 
of the radiotracer, as this is higher in areas with high bone remodeling. The age of the 
patient has a fundamental role in the appearance of the scan, especially during the growth 
period and in the elderly. In children, as they have a growing skeleton, there is a diffuse 
bone uptake and a striking uptake at the growth plates of bones, especially in metaphyseal-
epiphyseal areas of long bones and cranial sutures. This decreases over the years until 
complete fusion of the epiphyses takes place. On the other hand, bone scan images are often 
of poor quality in old people. Aging may be reflected in scintigraphic images by a diffuse 
reduction of bone uptake of the radioisotope, although diffuse uptake at the dome or 
symmetrical uptake in the peripheral joints (secondary to osteoarthritis) may be present. 
Associated degenerative processes may lead to increased uptake in the involved joints. 
Obese people also get lower quality images. In addition, insufficient hydration and/or renal 
failure hamper the radiopharmaceutical removal of soft tissues and modify the end result.  
The sternum and the sacroiliacs joints are normal uptake areas in scintigraphic studies (Fig. 
1). Other areas that may appear as normal increased uptake (table 1) are forewings of the 
iliac bone, coracoid process, tip of the scapula and, sometimes, costochondral junction, 
lower portion of the cervical spine, kneecaps and some muscle attachments. Thoracic 
kyphosis and lumbar lordosis may cause the parts of the column that are farther away, 
appear as less warm. In patients with scoliosis, concave side usually appears hotter than the 
convex. There is also a physiological uptake located at renal pelvis and the bladder, since 
radiotracers are eliminated by the kidneys (Murray, 1998; Schneider, 2006).  
www.intechopen.com
 
Nuclear Medicine in Musculoskeletal Disorders: Clinical Approach 
 
99 
 
Fig. 1. Normal bone scintigraphy. 
 
Head and neck:       Skull sutures, pterion, occipital protuberance, angle of mandible, 
hyperostosis frontalis, sinuses (ethmoidal and maxillary), dental 
disease and microcalcification of thyroid cartilage 
Thorax:  Sternoclavicular joint, acromioclavicular joint, sternal foramina, 
costochondral uptake, manubrium sternum/xiphisternum, tip of 
scapulae, symmetrical muscle insertion in the posterior ribs of 
paraspinal muscles (stippled appearance) 
Abdomen and pelvis:  Kidney, bladder, bladder diverticulae, pelvic diastasis (post 
partum women) 
Long bones:   Deltoid tuberosity/deltoid insertion, trochanteric bursitis 
Table 1. Normal Variants of uptake on 99mTc-MDP Bone Scan. 
Many causes may lead to false pathologic imaging or pitfalls (Naddaf et al., 2004). Bladder 
diverticula or bladder image over pubic bones, urine leakage or urinary retention and patient 
rotation are some common examples. Artifacts on bone scintigraphy can be technical or 
patient-related (Table 2). The technical artifacts include equipment, radiopharmaceutical, and 
image processing-related problems. Equipment-related artifacts may be due to inadequate 
quality-control procedures and calibration. Faulty radiopharmaceutical preparation alters 
biodistribution and can compromise the diagnostic quality of the images. Increased tracer 
uptake in the stomach, thyroid, and salivary glands can be seen if there is free pertechnetate, in 
the radiopharmaceutical. A number of factors, for example, presence of reduced aluminum 
ions, if the radiopharmaceutical is left unused for a long time, inappropriately high pH and 
addition of dextrose solutions, may affect uptake of radioactivity in bone. 
Finally, the most common artifact on the bone scan is due to extravasation at the site of 
injection, that may occasionally cause confusion with a bone abnormality, and it is therefore 
important to document the site of injection in all patients. Further, ipsilateral lymph node(s) 
may be seen due to extravasation of radiotracer and can on occasion cause confusion,  
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Radiopharmaceutical: Free pertechnetate (stomach, thyroid, salivary glands) 
Technical:  Injection site, lymph node (radiotracer extravasations), 
injection into central venous catheter, arterial injection 
Patient:  Urine contamination, patient motion, breast prosthesis, 
metallic prosthesis (elbow, shoulder, knee and hip) 
Metallic:    Belt buckle, medallion, jewellery, pace maker 
Instrumentation:    Photomultiplier tube, cobalt peak, image contrast 
Treatment:  Postradiotherapy
Table 2. Common Artifacts in Bone Scintigraphy. 
particularly if overlying the scapula or a rib (Gnanasegaran et al., 2009). Photon-deficient 
areas commonly seen on the bone scan are due to metallic objects. Patients should be asked 
to remove metallic objects wherever possible before performing the scan.  Urinary 
contamination is a common problem, which may simulate focal lesions, especially if close to 
or overlying the bone. It is useful to remove the clothing or to wash the skin and reimage the 
patient around the region of interest to avoid any confusion. The patient should void before 
the study and rarely delayed imaging or bladder catheterization may be required. Further, 
radioactive urine in the bladder is a frequent cause of artifact in patients evaluated with 
SPECT for pelvic metastases (prostate cancer) or low-back pain. Increased radioactive urine 
in the bladder can cause streak artifacts on the reconstructed images and overlap bony 
structures. Further, intense tracer retention in the bladder is reported to cause pixel 
overload, resulting in a relatively cold area close to the region of interest of the femoral 
heads, which hinders its interpretation.  
3. Rheumatoid arthritis 
Rheumatoid arthritis (RA) is a chronic autoimmune systemic disease of unknown origin, 
with an overall prevalence of 1%. It mainly affects joints with symmetrical and polyarticular 
pattern and may lead up to progressive structural damage, functional disability and extra–
articular complications. It can affect many organ systems and it is also associated with a 
higher prevalence of other diseases such as infections, neoplasms and cardiovascular 
disease. It has been shown that 50% of patients with RA are disabled within 10 years of 
onset of disease and survival is reduced (Malviya et al., 2010; as cited in Solomon et al., 2003, 
Wolfe et al., 1994, 2002, 2003).  
Conventional radiology is the most wide-spread technique for the appraisal of RA, since it 
allows the evaluation of the presence or absence of erosions, joint space narrowing or 
articular osteopenia, but only when symptoms have been present for several months or 
years. The importance of early diagnosis in patients with RA, based on the possibility of 
modifying the prognosis with an early treatment, has led to the introduction of new 
techniques that identify the characteristic changes in an accurate and reliable way. MRI and 
High-Frequency Ultrasonography (US) have shown their reliability for detecting early bony, 
vascular and soft tissue changes in patients with RA and are the techniques most commonly 
used with this aim. Nuclear medicine techniques, such as imaging with nanocolloids, PET or 
three-phase bone scintigraphy may also be useful in this field. Three-phase bone 
scintigraphy is still used in clinical practice in patients with RA because it allows the 
detection of changes (hyperemia, increased permeability, altered bone metabolism) before 
the structural lesions appear, and may display the pattern of joint involvement and even 
predict the development of erosions (Colamussi et al., 2004; as cited in Mottonen et al., 
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1988). The intensity of uptake on scintigraphy is correlated to some clinical and laboratory 
indexes of disease activity (De Leonardis et al., 2008; as cited in Park et al., 1977) and the 
monitoring during treatment can evaluate the effectiveness of it (De Leonardis et al., 2008; as 
cited in Palmer et al., 1993; Elzinga et al., 2010). It is also a useful technique when an 
additional pathology (eg, osteonecrosis, stress fractures or metastatis) is suspected.  
Furthermore, in patients with nonspecific polyarthralgia, normal bone scan excludes the 
presence of active arthritis (Colamussi et al., 2004; as cited in Shearman et al., 1982). It is a 
sensitive tool but not highly specific, and may be altered in other diseases such as 
osteoarthritis. Nevertheless, planar bone scintigraphy is clearly less sensitive than SPECT in 
the evaluation of early stages of this disease or mild abnormalities. Multipinhole SPECT of 
the hands has been used to identify patients with minimal changes in bone metabolism 
(Gotthardt et al., 2010). This technique proven to equal MRI in sensitivity and also detected 
increased bone metabolism in two patients in whom MRI had negative results, 
demonstrating that multipinhole SPECT may be even more sensitive than MRI in some 
cases (Gotthardt et al., 2010; as cited in Ostendorf et al., 2010). PET may also be used for 
imaging of synovial inflammation. The most commonly used radiotracer in clinical PET 
scanning is fluorodeoxyglucose (18F-FDG), and since inflammation is a glucose-avid 
oxidative process, 18F-FDG-PET allows a quantitative measurement of the uptake of tracer 
concentration with a positive correlation with the degree of joint inflammation in patients 
with RA. Recently, it has been demonstrated its correlation with parameters of disease 
activity (swelling, tenderness, serum markers) and findings from gold standard techniques 
such as US and MRI. This quantitative assessment could be useful for evaluating the 
therapeutic effectiveness. Besides 18F-FDG, tracers such as 11C-choline may be used for 
measurement of cell proliferation and evaluation of synovitis with high accuracy (Gotthardt 
et al., 2010; as cited in Roivainen, 2003). Other techniques, including the imaging of sinovitis 
with 99mTc-nanocolloids, have shown high sensitivity and specificity in this field. Thus, 
nuclear medicine techniques, especially PET and multipinhole SPECT of small joints, may 
play a role in identifying RA at an early stage, but the usefulness of these techniques 
compared with MRI and US needs to be proven in RA imaging. Currently, US and MRI are 
the techniques of choice for serial assessments of patients with RA due to practical reasons 
and the required exposure of the patient to radiation in the nuclear medicine studies. Large 
systematic prospective studies on the efficient use of imaging modalities to assess the 
efficacy of treatment in early RA are lacking. Nevertheless, new imaging modalities are 
assuming an important role in the investigation and management of RA. Tagging important 
cellular and protein mediator may allow us improving the knowledge of RA 
pathophysiology. In recent years, the use of labelled immunoglobulins (Igs) that head for 
areas of inflammation and where they stay accumulated (aspecific polyclonal IgG-type 
antibodies labelled in most cases with Tc-99m), has been developed (Table 3).  
 
mAbs     Type   Class    Isotope Target 
Infliximab (Remicade)   Chimeric  IgG1   
Adalimumab (Humira)   Fully human  IgG1   
Rituximab (Rituxan/Mabthera)  Chimeric  IgG1  
MAX.16H5                                   Murine   IgG1  
1.2B6    Murine   IgG1   
OKT-3 (Muromonab)  Murine  IgG2  
99mTc  
99mTc  
99mTc  
99mTc  
111In  
99mTc  
TNF-ǂ 
TNF-ǂ 
CD20 
CD4 
E-selectin 
CD3 
Table 3. Molecular imaging of RA by radiolabelled monoclonal antibody (mAbs). 
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The immunoscintigraphy has proven to be more sensitive than clinical examination for 
identifying synovitis and have a high positive predictive value for the onset of RA in 
patients with nonspecific arthropathy, and its usefulness for monitoring and assessing 
treatment response (Colamussi et al., 2004; as cited in De Bois et al., 1995a, 1995b, 1996). It 
can also be used to detect infection, although the preferred technique in these cases is 
labelled leukocyte scintigraphy, in which two tracers are often used: 99mTc-HMPAO or 
111In-oxine (De Gersem & Jamar, 2010). Labelled leukocyte scintigraphy is also useful in 
assessing therapeutic response in RA patients and it has been correlated with other indices 
of activity in this disease (Collamussi et al., 2004; as cited in Al-Janabi et al., 1988). However, 
immunoscintigraphy seems to be more accurate than labelled leukocyte scintigraphy for the 
identification of synovitis in RA (Collamussi et al., 2004; as cited in Liberatore et al., 1992). 
Other molecules and receptors (e.g. 64Cu-labelled anti-GPI, 68Ga-labelled annexin V or 
123I-antileukoproteinase) are being identified as therapeutic targets and used to develop 
new radiopharmaceuticals which accumulate in areas of inflammation where they can be 
located and quantified. Their study and description will allow improving the understanding 
of the complex pathophysiology of RA and detecting changes in very early stages of this 
disease and will give us the possibility of a pre-therapy scintigraphic approach with 
radiolabelled monoclonal antibodies that will let us evaluate the presence of target 
molecules in the inflammatory lesion, thus helping in the selection of the most efficient 
therapy and predicting therapy response (Glaudemans et al., 2010; Malviya et al., 2010). But 
currently, these techniques are not used in clinical practice and remain like a research tool 
inside selected laboratories. Bioluminescence and fluorescence reflectance imaging are other 
approaches that allow imaging, and potentially the delivery of therapeutic agents at a 
molecular level (McQueen & Ostergaard, 2007). 
4. Sacroilitis 
Sacroiliac joint involvement is a common finding in the spondyloarthropathies (SpA) group 
and it is an important parameter included in the diagnostic criteria. Conventional radiology 
is essential in the evaluation of the sacroiliac joints, but it does not detect early abnormalities 
and, therefore, the use of other complementary techniques currently available, such as CT, 
MRI, US, and bone scintigraphy, is necessary to avoid delaying the diagnosis.  
Until only a few years ago, bone scintigraphy was the gold standard technique for early 
diagnosis of inflammatory processes at this joint. The assessment of sacroilitis by 
scintigraphy is based on the quantification of radiotracer uptake in the sacrum and sacroiliac 
joints. This technique can help to differentiate between degenerative and inflammatory 
disorders in patients with nonespecific radiological changes. Both conventional bone 
scintigraphy and SPECT mode are sensitive techniques for early detection of SpA in patients 
with low back pain and who still do not have typical radiological changes, because the 
uptake of radiopharmaceutical at sacroiliac joints is produced before structural damage 
happens. However, in the sclerotic phase of evolved SpA, scintigraphy frequently does not 
detect any abnormalities. MRI, more sensitive in detecting early changes and more specific, 
has shifted to the bone scan. In this regard, a published review (Schneider, 2006; Song et al., 
2008) realized with the aim to assess the diagnostic value of scintigraphy for detecting 
sacroilitis in patients with established and/or probable ankylosing spondylitis, has proven 
limited value of scintigraphy both in the early detection of sacroilitis and in patients with 
established ankylosing spondylitis. In patients with SpA and gastrointestinal symptoms but 
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negative endoscopic or radiological test results, abdominal scintigraphy with labelled 
leukocytes can be used to assess the abdominal involvement (Colamussi et al., 2004; as cited 
in Elkayam et al., 2002). 
5. Infection 
In the setting of infection four entities can be established: osteomyelitis, septic arthritis, soft 
tissues infections and joint replacement infection. 
5.1 Osteomyelitis 
Osteomyelitis is defined by infection localized to bone. It can occur as a result of 
hematogenous seeding, contiguous spread of infection to bone from adjacent soft tissues 
and joints, or direct inoculation of infection into the bone as a result of trauma or surgery 
(Lalani, 2011). Three-phase bone scan with 99mTc-hydroxymethylene diphosphonate or Tc-
99m-MDP has long been used as the standard method for the detection of osteomyelitis 
(Gotthard et al., 2010), and positive focally increased uptake on all three phases (Fig. 2) is 
usually seen (Love et al., 2003). 
 
 
Fig. 2. Three-phase bone scan: Focally increased uptake on all three phases in a patient with 
osteomyelitis of the right great toe. 
In contrast, in the setting of cellulitis there is increased activity only in the first two phases and 
normal or mild diffuse increased activity in the third phase (Brown et al., 1993; Horwich, 2011). 
Radiographic studies do not show any change for at least 1- 2 weeks after initial infection, 
contrary to the three-phase bone scan where imaging of the infection can be seen in the first 24 
- 48 hours of the infection (Díaz & De haro, 2005).  Bone scintigraphy has a high sensitivity 
exceeding 80% and a limited specificity reaching up to 50% (Gotthard et al., 2010, as cited in 
Hakim et al., 2006; Palestro et al., 2002). The limited specificity can be explained by uptake of 
the radiopharmaceutical at all sites of increased bone metabolism irrespective of the 
underlying cause. Other conditions such as tumors, fractures, joint neuropathy may mimic 
osteomyelitis at three-phase bone scintigraphy. To improve specificity, complementary 
imaging with gallium-67 (67Ga) citrate (for spinal infection) or indium-111-labelled autologous 
leukocytes (for the appendicular skeleton) is often performed (Love et al., 2003).  
Gallium scans utilize the affinity of gallium-67 to acute phase reactants (lactoferrin, transferrin, 
and others) to demonstrate areas of inflammation that may be related to infection (Horwich, 
2011). Intense uptake on 67Ga bone scintigraphy in two adjacent vertebrae with loss of the disc 
space is highly suggestive of spinal osteomyelitis (Palestro & Torres, 1997). This method is 
quite sensitive and more specific than three-phase bone scan (Horwich, 2011; as cited in 
Palestro, 1991; Tumeh, 1986). It is typically performed 24 hours following inyection and 
therefore should be reserved for patients who are clinically stable and do not require prompt 
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imaging results for urgent management decisions. Gallium not only enhances the specificity of 
the diagnosis but provides information about surrounding soft tissue infection (Palestro & 
Torres, 1997). If gallium scan is negative, it effectively excludes the diagnosis of osteomyelitis 
(Horwich, 2011; as cited in Pineda, 2006). A gallium scan can be performed concurrently with a 
technetium labelled three-phase bone scan, and the information gathered may be more useful 
than that of either examination alone (Horwich, 2011; as cited in Tumed, 1986). Both 
radionuclides can be injected at the same time and the scintigraphic images can be obtained 
three to four hours after injection, while gallium images will be obtained up to 24 hours later 
(Horwich, 2011). This combination is probably the best nuclear medicine tool for the 
evaluation of vertebral osteomyelitis (Palestro & Torres, 1997).  
Labelled leukocyte imaging is a good alternative in the evaluation of osteomyleitis, but is of 
little value in vertebral osteomyelitis because this entity often presents as a non specific 
photopenic defect (Gotthard et al., 2010; as cited in Van Der Bruggen et al., 2010). But, in the 
diabetic foot diagnosis, labelled leukocyte imaging alone is sufficient to determine the 
presence of osteomyelitis in the forefoot. In the midfoot and hindfoot it may be necessary to 
combine leukocyte scintigraphy with others radiotracers to precisely localize the infection 
(Palestro & Torres, 1997). The combined imaging approach of 99mTc-colloid bone 
marrow/labelled-leukocyte scanning enhances the sensitivity and specificity above 90%, 
avoiding the problem of physiologic uptake into bone marrow. Because in osteomyelitis 
bone marrow is replaced by the infectious process, bone marrow imaging will be negative 
whereas leukocyte scanning in the same location will be positive (Gotthardt et al., 2010, as 
cited in Palestro et al., 2006).  
In chronic osteomyelitis the specificity of Tc-99m-MDP bone scans is very low even with 
active exacerbation because positive uptake also occurs with the healing process (El-
Maghraby et al., 2006). Other false negative results are possible in areas of relative ischemia, 
since radiotracer may not be adequately delivered to the target site (Horwich, 2011). 67Ga 
combined with Tc-99m-MDP allows identification of active chronic osteomyelitis. 
Discordance between 67Ga and Tc-99m-MDP with more intense 67Ga or different 
distribution is highly specific at 80-100% (El-Maghraby et al., 2006). 18F-FDG-PET is a 
promising modality for imaging musculoskeletal infection and might play an important role 
in the evaluation of chronic osteomyelitis and spinal infection (Strobel & Stumpe, 2007).  The 
specificity for spinal infection drops only if patients underwent surgery less than 6 months 
before PET and if osteosynthetic material is present (Gotthardt et al., 2010; as cited in De 
Winter et al., 2003). However, because MRI may not be an option in patients with metallic 
implants in situ, PET currently is the most sensitive imaging modality in the evaluation of 
such patients (Gotthardt et al., 2010; as cited in De Winter et al., 2003). Furthermore, in cases 
of severe defenerative disk disease with oedema-like changes in the endplates and the 
adjacent discs, MRI can give false-positive results (Gotthardt et al., 2010; as cited in Palestro 
et al., 2006). Other tracers for diagnosing spinal osteomyelitis are also under investigation, 
including radiolabelled antibiotics and antifungical tracers (Gemmel et al., 2006). 
5.2 Septic arthritis 
Septic arthritis is the infection of the synovial tissues. It often occurs as a result of 
hematogenous seeding and less often by direct inoculation as a result of trauma or surgery 
(Díaz & De haro, 2005). Although it may occur at any age, it is most common in children 
under 3 years. Over 90% of cases are mono-articular (El-Maghraby et al., 2006). The most 
commonly involved joints are the hips and the knees (Díaz & De haro, 2005). Despite MRI  
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and nuclear medicine methods are used for the diagnosis or a preliminary investigation of 
infectious arthritis, the definitive diagnostic test is the identification of bacteria in the 
synovial fluid aspiration (Díaz & De haro 2005). Though, some joints are difficult to 
examine. As in the osteomyelitis, there is an increased uptake on all three phases of three-
phase bone scan (El-Maghraby et al., 2006). The hallmark of septic arthritis is symmetrical 
uptake in both sides of the joint (Díaz & De haro, 2005). However, a positive scintigraphy 
has a low specificity. The differential diagnosis is made more accurate when the 
osteoarticular scintigraphy is combined with gallium citrate or more commonly 
radiolabelled leukocyte or immunoglobulins. In the presence of septic arthritis, these agents 
demonstrate activity patterns of diffuse nature in the soft tissue in and around the joint with 
no focal abnormality in bone. However, this can be difficult to ascertain without 
demonstration of exactly where bone lies in relation to the soft tissue infection and may 
need combined imaging. Rosenthall et al have shown that a combined study does raise the 
sensitivity for the detection of septic arthritis from 54% with TC-99m-MDP alone to 84% for 
combined 67Ga/Tc-99m-MDP scanning (El-Maghraby et al., 2006; as cited in Rosenthall et 
al., 1982). Another combination is the labelled leukocytes/Tc-99m-MDP combined study, 
which is reported to be more specific than a 67Ga/Tc-99m-MDP study and produces fewer 
equivocal results (El-Maghraby et al., 2006; as cited in Tehranzadeh et al., 2001; Chengazi & 
O’Mara, 2003). For disc space infections, although the bone scan is often positive, gallium 
scintigraphy is the preferred method. Indium-111(111In)-leukocytes have been shown to be 
of limited value in the diagnosis of disc space infection; although some authors feel that the 
labelled white cell scan can be of benefit especially if the cold (photon deficient) lesions are 
considered diagnostic of disc space infection (Brown et al., 1993). 
5.3 Cellulitis 
Cellulitis is a soft tissue infection. The scan shows intense uptake in the first two phases of 
the study with diffuse extra-osseous activity, while the final image is normal after 2-4 hours. 
The presence of other processes that stimulate osteoblastic reaction, as in cases of suspected 
osteomyelitis in areas with trauma, surgery or arthritis, complicates the interpretation of the 
scintigraphic image which is completely non specific. Combined studies with different 
radiotracers such as 67Ga, 111In-leukocytes or 99mTc-HM-PAO improve the sensitivity and 
specificity, although MRI remains as gold standard technique (Díaz & De Haro, 2005). 
5.4 Painful joint replacement 
Prosthetic joint replacement is a common procedure and most patients have excellent results, 
but 20% of them develop pain during the follow-up. It may be secondary to infection, aseptic 
loosening or heterotopic bone formation (El-Maghraby et al., 2006). Differentiate betweeen 
loosening and infection is often a difficult problem, especially because clinical signs and 
symptoms, laboratory tests and radiographies are insensitive, nonspecific, or both. Cross-
sectional imaging modalities are hampered by artifacts produced by the prosthetic devices. 
Radionuclide imaging is not affected by the presence of metallic hardware and is therefore 
useful for evaluating the painful prosthesis (Love et al., 2001). Negative scintigraphic study 
rules out septic or aseptic loosening. Both conditions, however, may show increased tracer 
uptake in bone scans, but the pattern and site of uptake may help to differentiate each other. In 
aseptic loosening, focal localized uptake at the tips is seen, whereas in the infection diffuse 
intense uptake will be seen in the three phases of bone scan. The sensitivity for bone scan in 
infection is relatively high, ranging from 70% to 100% but the specificity is variable ranging 
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from 20% to 90% and the reported accuracy is around 50-70% (El-Maghraby et al., 2006; as 
cited in Rosenthall et al., 1982, Turpin & Lambert, 2001, Wilson, 2004). The combination of 
67Ga-citrate and Tc-99m-MDP bone scans has better results, with accuracy around 70-80% (El-
Maghraby et al., 2006). But lower results for this combination has also been reported because 
the uptake of both tracers can be found not only in infection, but also in the postoperative 
patient, in heterotopic bone formation, and loosening or inflammatory reaction to cement 
fixators (El-Maghraby et al., 2006; as cited in Turpin & Lambert, 2001). 
Labelled leukocyte imaging is, at least theoretically, the ideal technique for diagnosing the 
infected prosthesis because in general, white cells do not accumulate at sites of increased bone 
mineral turnover in the absence of infection (Palestro, 1998). However, labelled-leukocytes 
yield false positive results due to reactive or displaced bone marrow as a result of surgery are 
present up to more than 24 months after implantation (El-Maghraby et al., 2006; as cited in 
Oswald et al., 1990). Labelled leukocytes accumulate not only in infection but in the bone 
marrow as well. This problem has been overcome by the addition of complementary bone 
marrow imaging, which is usually performed with Tc-99m sulfur colloid. Both, labelled 
leukocytes and sulfur colloid accumulate in the bone marrow, but only labelled leukocytes 
accumulate in infection. In contrast to the results reported for labelled leukocyte imaging 
alone, the results of combined leukocyte-marrow imaging of prosthetic joints have been 
uniformly excellent, with an accuracy of 90% or greater (Love et al., 2001; as cited in Palestro 
1990, 1991) and has become the method of choice to evaluate surgical prostheses (El-Maghraby 
et al., 2006; as cited in Love et al., 2001; Turpin & Lambert, 2001). Although extremely accurate, 
leukocyte-marrow scintigraphy is hampered by significant limitations. The in vitro labelling 
process is labor intensive, is not always available, and requires direct contact with blood 
products. The need for marrow imaging adds to the complexity and cost of the study and is an 
additional inconvenience to patients, many of whom are elderly and debilitated (Love et al., 
2001). In an effort to maintain the accuracy of the study while reducing or eliminating the 
disadvantages, several methods of labelling leukocytes in vivo have been investigated, but 
their role in prosthetic joint infection has not been established.   
FDG-PET has been extensively investigated, the high-resolution tomographic images, 
availability of the agent, and rapid completion of the procedure are all desirable traits. 
Published results to date, however, are inconclusive in this setting (Love et al., 2009; as cited 
in Chacko et al., 2002; Joseph et al., 2001; Love et al., 2004; Manthey et al., 2002; Pill et al., 
2006; Reinartz et al., 2005; Stumpe et al., 2004; Zhuang et al, 2001). 
6. Avascular osteonecrosis  
Osteonecrosis, also known as aseptic necrosis, avascular necrosis, ischemic necrosis, and 
osteochondritis dissecans, is a pathological process that has been associated with numerous 
conditions and therapeutic interventions. The exact prevalence of osteonecrosis is unknown. In 
the United States, there are an estimated 10,000 to 20,000 new patients diagnosed per year, and 
osteonecrosis is the underlying diagnosis in approximately 10 percent of all total hip 
replacements. The male-to-female ratio of this disorder is 8:1, but varies with different 
comorbidities (Jones, 2011). The mechanisms by which this disorder develops are not fully 
understood. Compromise of the bone vasculature leading to the death of bone and marrow 
cells (bone marrow infarction) appear to be common to most proposed etiologies. The process 
is most often progressive, resulting in joint destruction within three to five years if left 
untreated. A variety of traumatic and nontraumatic factors contribute to the etiology of 
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osteonecrosis. Glucocorticoid use and excessive alcohol intake are reported to be associated 
with more than 90% of the cases. Osteonecrosis usually occurs in the anterolateral femoral 
head, although it may also affect the femoral condyles, humeral heads, proximal tibia, 
vertebrae, and small bones of the hand and foot. Many patients have bilateral involvement at 
the time of diagnosis, including disease of the hips, knees, and shoulders. The most common 
presenting symptom of osteonecrosis is pain and patients may have eventually limitation on 
range of motion. A limp may be present late in the course of lower extremity disease. A small 
proportion of patients are asymptomatic. In these cases the diagnosis is usually incidental. 
Asymptomatic involvement contralateral to a symptomatic site is frequently noted.  
There is no pathognomonic feature of osteonecrosis. A clinical diagnosis is appropriately 
made in a symptomatic patient when imaging findings are compatible with this disease and 
other causes of pain and bony abnormalities are either unlikely or have been excluded by 
appropriate testing. The evaluation for suspected osteonecrosis should begin with plain film 
radiography, althought it can remain normal for months after symptoms of osteonecrosis 
begin. Features of osteonecrosis on plain film radiographs, radionuclide scans (Fig. 3), and 
MRI are helpful diagnostically and provide the basis for classification and staging systems. 
Early diagnosis of osteonecrosis is crucial: the earlier the stage of the lesion at the time of 
diagnosis, the better the prognosis. Clinically, early diagnosis and treatment of osteonecrosis 
might prevent unnecessary surgery (Pape et al., 2004). Therefore, early diagnosis and 
location of osteonecrosis have prognostic value and determine the therapeutic alternatives.   
 
 
Fig. 3. Radionuclide bone scan of the pelvis in a 68-year-old man with hip pain. Bilateral 
central area of diminished uptake surrounded by a zone of increased uptake in the femoral 
head consistent with avascular necrosis. 
Currently, MRI is the technique of choice for the diagnosis of avascular osteonecrosis in the 
early stages. This technique has been proven to be a highly accurate method both for early 
diagnosis (changes can be seen early in the course of disease when other studies are negative) 
and for staging of the disease (Malizos et al., 2007). MRI is far more sensitive than plain 
radiographs or bone scanning, with an overall reported sensitivity of 91% (Jones, 2011; as cited 
in Chang et al., 1993). Nevertheless, 99mTc bone scintigraphy also plays an important role in 
the early diagnosis of avascular necrosis and whole body bone scan is useful in patients with 
suspected polytopic osteonecrosis. The characteristic distribution of the radiopharmaceutical  
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in the affected area (cold area surrounded by a hyperfixation rim) enables early diagnosis, 
before the appearance of anatomical changes, which only show up later with radiography 
(Jones, 2011; as cited in Feggi et al., 1987 and Maillefert et al., 1997). The presence of this tipical 
pattern may increase the diagnostic accuracy to distinguish between osteonecrosis and 
transient osteoporosis, which usually has a diffuse pattern of tracer uptake, with no cold area. 
The accuracy of scintigraphy can be improved by using SPECT in patients with suspected 
avascular necrosis of the femoral head but have concomitant changes that may show up as 
false positives, such as severe acetabular osteoarthritis (Jones, 2011; as cited in Collier et al., 
1985). It also may help us to avoid overlooking a subchondral fracture. 
6.1 Transient osteoporosis 
Transient osteoporosis of the hip, also called transient marrow edema syndrome, is 
characterized by the presence of intense radionuclide uptake in the femoral head, which may 
extend to the femoral neck, to the intertrochanteric region, or to proximal femoral diaphyseal 
region. It is also typical to find hyperactivity at the images of flow phase and blood pool 
phase. Ischemia of the femoral head, that has not caused necrosis, has been suggested as a 
possible cause of this process. The reactive hyperemic response to this ischemic phenomenon, 
with a repair process, would explain scintigraphic changes. Insufficiency fractures in this 
location can provide similar scintigraphic imaging (Schneider, 2006). 
7. Reflex sympathetic dystrophy 
Reflex sympathetic dystrophy (RSD) is a complex physiologic response of the body to an 
external stimulus resulting in pain sympathetically mediated, usually nonanatomic pattern, 
which is out of proportion to the inciting event or expected healing response (Fournier & 
Holder 1998).  It is a syndrome affecting an extremity after a minor trauma or surgery, but the 
particular mechanism remains uncertain. The diagnosis of RSD relies on clinical evaluation, 
scintigraphy or MR imaging, and routine radiographs. In the spontaneous course of this 
syndrome three phases can be distinguished: Stage I is the warm or hypertrophic phase, stage 
II is called the cold or atrophic phase and the third stage corresponds to stabilization or, in rare 
instances, to healing (Driessens et al., 1999; Ornetti & Maillefert, 2004). 
 
 
Fig. 4. Bone scanning: Diffusely increased uptake in the distal right upper extremity in reflex 
sympathetic dystrophy. 
Three-phase scintigraphy has been widely utilized in both the diagnosis and monitoring of 
treatment (Murray, 1998). Scintigraphy imaging (Fig. 4) shows increased perfusion during 
the angiographic and vascular pool phases and widespread increases in radiophosphonate 
bone uptake in the late stage (Colamussi et al., 2004). The highest diagnostic accuracy is  
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provided by the combination of three signs: Increase activity ratio in the blood pool phase 
performed at 5-15 min, diffuse uptake in the carpus o tarsus and periarticular uptake in all 
the small joints (Murray, 1998). Decreased radiotracer accumulation has also been described, 
especially in children and adolescents (Driessens et al., 1999; Love et al., 2003). Bone 
scintigraphy is of major importance for the diagnosis in order to clearly differentiate from 
other conditions which are incorrectly diagnosed and treated as RSD. If the bone scan is not 
suggestive of RSD, the clinical picture, radiological examination and vascular scan may lead 
to the correct diagnosis. This may be a pseudodystrophy, in which a hypovascularization is 
found right from the start, while in true RSD there is initially a hypervascularization. Other 
conditions which may be confused with RSD are causalgia, neurotic compulsive postures, 
hysterical conversion, malingering and even self-mutilation (Driessens et al., 1999). Bone 
scintigraphy has a high sensitivity in the initial stage of Sudeck's syndrome, but after 26 
weeks, it loses accuracy (Benning & Steinert, 1988; Lee & Weeks, 1995). 
8. Metabolic bone disorders 
8.1 Osteoporosis 
Osteoporosis is defined as a systemic skeletal disease characterized by low bone density and 
microarchitectural deterioration of bone tissue, with an increase in bone fragility and 
susceptibility to fractures. Despite an increase in bone turnover that is usually present in 
osteoporosis, the bone scan has no role in the diagnosis of uncomplicated osteoporosis, but the 
Tc-99m-MDP bone scan is most often used in established osteoporosis to diagnose fractures, 
particularly at sites that are difficult to image with plain film radiography (eg, sacrum, ribs), 
and may be particularly useful in the diagnosis and timing of vertebral fractures. It also has an 
important role in assessing suspected fractures where radiography is unhelpful, either because 
of poor sensitivity related to the anatomical site of the fracture (eg, sacrum Fig. 5) or because 
adequate views are not obtainable because of the patient’s discomfort (Fogelman & Cook, 
2003). The characteristic appearance of these fractures is discussed elsewhere in this chapter. If 
a patient complains of back pain with multiple previous vertebral fractures noted on  
 
 
Fig. 5. Posterior and anterior Tc-99m-MDP bone scan showing a typical “H-shaped” pattern 
in the sacrum, indicating a sacral insufficiency fracture. 
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radiographs, and the bone scan is normal, then this essentially excludes recent fracture as the 
cause of symptoms and other causes of pain should then be considered. 
8.2 Paget 
Paget's disease is a localized disease of bone remodeling characterized by an increased bone 
resorption mediated by osteoclasts and a compensatory increase in bone formation. The 
result is a disorganized mosaic of woven and lamellar bone at affected skeletal sites. This 
structural change produces bone that is expanded in size, less compact, more vascular and 
more susceptible to deformity and fracture than in normal bone. It can affect any bone, but 
is more common in skull, hip, pelvis, legs and back. Paget’s disease may be monostotic, but 
the majority of patients have a polyostotic disease (80-90%). Most patients are 
asymptomatic, but they can experience a variety of symptoms such as bone pain, bone 
deformity, secondary arthritic problems, excessive warmth over bone area and different 
neurological complications caused by compression of adjacent neural tissues. 
Bone scintigraphy, combined with radiology, is the technique of choice for assessing the 
location and extent of the pagetic bone lesions. It allows of evaluating the entire skeleton 
and is more sensitive than radiography in identifying metabolically active lesions (Fogelman 
& Carr, 1980): there is no radiological correspondence over 10% of scintigraphic hot spots 
(Devogelaer & De Deuxchaisnes, 2003). Symptomatic lesions are usually characterized by an 
increased uptake. Characteristically, affected bones show a striking increase in metabolic 
activity that starts at one edge of the bone and extends distally or proximally, often showing 
a “V” or “flame – shaped” leading edge. Both osteolytic and osteoblastic lesions are 
associated with and increase in radiotracer uptake on bone scan (Fig. 6). Scintigraphic 
pagetic bone features are usually characteristic, presenting as "hot spots". Whole bone may 
be affected, especially at pelvis, scapula and vertebrae. Abnormal tracer accumulation 
throughout the vertebra, affecting the body and posterior elements, is the characteristic 
finding in this localization. The skull may show a different pattern with a ring of increased 
activity only in the margins of the lesion (Fogelman & Cook, 2003). The intensity of 
radiactive tracer uptake, usually Tc-99m-MDP, depends on the metabolic activity of Paget's 
disease. In later stages, the disease may go into a period of inactivity and bone scan shows 
little or no uptake. Therefore, bone scintigraphy is complementary to the use of biochemical 
markers (e.g. serum alkaline phosphatase, urine hydroxyproline) for the assessment of bone 
turnover and may be useful in assessing therapeutic efficacy, since a good correlation 
between bone scintigraphy uptake and clinical and biochemical markers has been found 
(Cook et al., 2010). Cases of scintigraphic evidence of pagetic activity in the setting of normal 
serum alkaline phosphatase have been reported. In these cases, bone scintigraphy is the 
main technique in the evaluation of the effectiveness of the treatment. Bone scan can be 
performed 3-6 months after treatment with bisphosphonates, although scintigraphic images 
may respond in a heterogeneous way (after intravenous bisphosphonate therapy, some 
bones may become normal, most bones show some improvement, and a small proportion 
remain unchanged), and even lead to infrequent images that sometimes mimic those of bone 
metastases. In these cases, knowing the medical history of the patient is essential (Fogelman 
& Cook, 2003). The superior quantitative accuracy of PET using 18F-fluoride ion has been 
described in the evaluation of pagetic bone (Cook et al., 2002), and this method has also been 
described to measure response to bisphosphonate treatment. An increase in 18F-FDG uptake 
has also been reported in pagetic bone (Cook et al., 2010; as cited in Cook et al., 1997), 
correlating also with disease activity. Bone scintigraphy can also identify complications (Fig. 
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6) of Paget's disease like fractures (shown as a linear area of increased activity perpendicular 
to the cortex) or sarcomatous degeneration. The latter should be suspected in patients with 
persistent pain. The most common scintigraphic sign in the setting of sarcomatous 
degeneration is a cold area inside an area of increased uptake. The scan may also show 
heterogeneous and irregular uptake in the study area or adjacent soft-tissue uptake. The 
evaluation of the lesion should always be completed with x-ray and, even if doubts persist, 
with an MRI, which could allow a more precise diagnosis (Fransen et al., 1998). 
 
 
Fig. 6. A Tc-99m-MDP bone scan showing Paget’s disease affecting the left humerus, mid-
thoracic and lower lumbar spine, sacrum, right 11th rib, left pelvis, left femur and tibia, and 
the right tibia. Focal linear activity in the right tibia indicates an incremental fracture 
8.3 Hyperparathyroidism 
Most cases of primary hyperparathyroidism are asymptomatic and are unlikely to be 
associated with changes on bone scintigraphy. The diagnosis is made biochemically and the 
use of bone scintigraphy does not make sense with this goal. But bone scan may be useful to 
differentiate the causes of hypercalcemia, in particular, hyperparathyroidism vs malignancy, 
so that typical features of metabolic bone disorders may be recognized. There is increased 
skeletal turnover in hyperparathyroidism, commonly seen as part of renal osteodystrophy, 
and in the more severe cases, this will be evident scintigraphically. A bone scan may show 
several features in hyperparathyroidism, but the most important is the generalized 
increased uptake throughout the skeleton that may be identified because of increased 
contrast between bone and soft tissues. This is commonly termed the metabolic superscan to 
differentiate from superscans caused by widespread bone metastases. Other typical features 
that have been described in this context include a prominent calvarium and mandible, 
beading of the costochondral junctions, and a “tie” sternum (Fogelman & Carr, 1980). Severe 
forms of hyperparathyroidism may be associated with uptake of bone radiopharmaceuticals 
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into soft tissue, related with ectopic calcification. Focal skeletal abnormalities may represent 
associated Brown tumors, although these are relatively uncommon. 
8.4 Renal osteodystrophy 
Renal osteodystrophy is secondary to a combination of bone disorders as a consequence of 
chronic renal dysfunction, and often shows the most severe cases of metabolic bone disease. 
It may include osteoporosis, osteomalacia, adynamic bone, and secondary 
hyperparathyroidism in varying degrees. The most frequent bone scan imagings are similar 
to a superscan from other metabolic bone disorders, and uptake of diphosphonate in areas 
of ectopic calcification also may be seen. A lack of bladder activity (secondary to the renal 
failure) may help in identification and differentiating this type of scintigraphic pattern from 
others. Aluminum toxicity from hemodialysis, rarely seen now, causes a poor quality bone 
scan with reduced skeletal uptake and increased soft-tissue activity, as aluminum blocks 
mineralization and hence the uptake of tracer, resulting in a pattern applicable to all forms 
of adynamic bone disease. Quantitative measurements of bone metabolism in renal 
osteodystrophy using 18F-fluoride have been compared with bone histomorphometry and 
have shown a close relationship between the net plasma clearance of 18F-fluoride to bone 
mineral and the histomorphometric indices of bone formation. The method was able to 
differentiate low turnover from high turnover states of renal osteodystrophy (Cook et al., 
2010; as cited in Messa et al., 1993). 
8.5 Osteomalacia 
Patients with osteomalacia usually demonstrate similar features of a bone scan as described 
in hyperparathyroidism, although in the early stages of the disease it may appear normal 
(Cook et al., 2010). The reason that osteomalacia shows these features is not fully 
understood. Tracer avidity may reflect diffuse uptake in osteoid, although more likely, it is 
due to the degree of secondary hyperparathyroidism that is present. In addition, the 
presence of focal lesions may represent pseudofractures or true fractures. Pseudofractures 
are characteristically found in the ribs, the lateral border of the scapula, the pubic rami, and 
the medial femoral cortices. Although osteomalacia is usually a biochemical and/or 
histologic diagnosis, the typical bone scan features can be helpful in suggesting the 
diagnosis. The detection of pseudofracutures with this technique is more sensitive than that 
with radiography (Cook et al., 2010; as cited in Fogelman et al., 1977, 1978). 
9. Bone tumors 
For the diagnosis study of primary bone tumors prevails the importance of the 
morphological study to characterize the lesion and, in many cases, the initial plain films 
guides the diagnosis. In these cases, the usefulness of bone scintigraphy is lesser, but may be 
useful for detecting a lesion that is difficult to assess radiologically because of its location, 
and supporting the suspicion about the benignity or malignancy of the lesion. Characteristic 
patterns of uptake have been described in some primary bone tumors, but they are not 
reliable enough, given that there is an overlap in the scintigraphic characteristics of the 
benign and malignant bone lesions. The differential diagnosis of a solitary bone lesion 
usually depends more on morphologic imaging techniques, including radiographs, CT, and 
MRI, and on expert histologic analysis. In contrast, a larger role is developing for 18F-FDG-
PET/CT for staging and response assessment of several bone tumors. Three-phase bone  
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scintigraphy offers information about the vascularity of the bone lesion: Malignant tumors 
tend to be more vascularized and be uptake in all three phases of the scan, while benign 
bone tumors often do not show changes in the first two phases of the scintigraphy. Normal 
uptake, even in the third stage, is a sign for the mildness of the bone lesion. Osteoid osteoma 
is a benign bone tumor that constitutes an exception to this statement: It is highly vascular 
and provides uptake images in all three phases of the scan. In fact, a normal bone scan 
excludes its diagnosis. Aneurysmal bone cyst may show similar features. In patients with a 
benign tumor and a bone scan showing intense uptake, a fracture should be suspected. 
9.1 Benign bone tumors and tumor- like disorders 
In benign bone tumors, the uptake of radiopharmaceuticals (e.g. 99mTc) varies by type of 
tumor and may be normal, mild or severe. Bone scintigraphy is useful for the diagnosis of 
osteoid osteoma, especially when it is located at the spine, pelvis or hip, where radiological 
studies are usually not diagnosed. The typical scintigraphic finding is a round focal uptake 
lesion. CT is always necessary to confirm the diagnosis and surgical treatment. Most 
enchondromas appear like hot spots at bone scan study. This technique can locate these 
tumors in multiple enchondromatosis, but it can not differentiate between enchondroma 
and chondrosarcoma. The scintigraphic feature of the giant cell tumor is increased tracer 
uptake in all phases of this study, and the image of donut of the lesion, with a rim of uptake 
surrounding a central area of low uptake. Nevertheless, this image may also appear in other 
bone tumors. In fibrous displasia, characterized by replacement of normal bone tissue by 
abnormal fibro-osseous tissue with a high bone turnover, bone scan also display areas of 
increased uptake. In other bone lesions such as Langerhans cell histiocytosis, hemangiomas 
and aneurysmal bone cysts, the sensitivity of this technique is variable (Schneider, 2006). 
9.2 Soft tissue tumors and primary malignant bone tumors 
Musculoskeletal sarcomas represent a heterogeneous group of malignancies involving bone 
and soft tissue. Multiple myeloma is the most common primary malignancy of bone in 
adults, with an incidence of 3 per 100,000 in the USA. It may affect any bone with 
hematopoietic red marrow. Patients affected are usually over 50 years of age with the most 
common age group being between 60 and 65 years of age. Excluding myeloma and 
lymphoma, malignant primary bone tumors constitute only 0.2% of all malignancies in 
adults and approximately 5% of childhood malignancies, and, excluding mieloma in adults, 
the overwhelming majority of cases consist of osteosarcoma or Ewings’ sarcoma (Green, 
2009). Both are more common in the pediatric than the adult population. Osteosarcoma is 
the most frequent primary bone malignancy in children and second in adults following 
multiple myeloma. The Ewing’s sarcoma family of tumors is the second most frequent 
primary bone malignancy in children and young adults and it is the most lethal bone tumor. 
The most common presenting symptom for primary bone tumors is a painful swelling 
arising in the bone. The presentation may be similar to acute or chronic osteomyelitis with 
systemic symptoms of fever, malaise, weight loss, and leukocytosis. Approximatly 15% of 
patients have clinically evident metastasic disease at diagnosis. Metastatic spread is mainly 
hematogenous, and the lungs are the most common site of metastases, followed by bone and 
bone marrow. Anatomic imaging techniques including radiography, US, CT and MRI, 
currently play a dominant role in the evaluation of suspected and known sarcomas of both 
soft tissue and bone. Nuclear medicine techniques such as scintigraphy, Thallium-201, and 
67Ga imaging have all been used in the assessment of primary bone tumors. However, PET 
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is becoming the most imporant modality for assessing biologic characteristics of the tumor, 
for primary staging, and for determining response to treatment. Although imaging studies 
may be highly suggestive of the diagnosis, they cannot reliably differentiate among the 
various types of malignant bone tumors, and even among malignant and benign conditions. 
Histopathologic confirmation, therefore, is required. The sites for biopsy are critical for 
accurate histological diagnosis and staging because biopsy of a small site may not represent 
the overall character of the tumor, missing high-grade areas, and non-diagnostic biopsies 
may also occur (Howman-Giles et al., 2006).  
The diagnosis of indeterminate bone lesions is limited with 18F-FDG-PET, but in general the 
greater the level of uptake, the more likely a lesion is malignant in nature. However, it has 
been reported that some giant cell tumors and fibrous dysplasia may show uptake equivalent 
to osteosarcomas and that some other benign bone lesions may show high 18F-FDG 
accumulation (Aoki et al., 2001). Despite this, 18F-FDG-PET has a high specificity for 
excluding malignant bone tumors (Cook et al., 2010). Recently, dual time point imaging and 
calculation of a retention index for 18F-FDG have shown improved discrimination of benign 
and malignant bone lesions compared with static measures, but that some overlap was still 
present (Tian et al., 2009). Lodge et al observed difference in time-activity curves between 
benign and low-grade malignant tumors that show peak activity within the first 30 minutes 
post-injection and high-grade sarcomas, which reach peak activity 4 hours after injection. 
This quantitative approach cannot separate low-grade sarcomas from benign lesions. MRI is 
the modality of choice to define the extension of tumors to surrounding soft tissue as well as 
to estimate the local tumor infiltration into bone marrow. However, in the pediatric 
population, 18F-FDG-PET is valuable for detection of skip metastases in cases of equivocal 
MRI findings due to the physiological red blood marrow in long bones (Even-Sapir, 2007; as 
cited in Wuisman P, Enneking WF, 1990). With the new hybrid imaging, it is now possible to 
take advantage of the metabolic and morphologic information from 18F-FDG-PET/CT to 
enhance discrimination between benign and malignant bone lesions by dedicated 
interpretation of the CT characteristics (Strobel et al., 2008). 18F-FDG-PET data can also assist 
in optimizing the biopsy site of heterogeneous masses by guiding sampling to active tumor 
sites and avoiding errors due to biopsy of necrotic tumor areas (Even-Sapir, 2007; as cited in 
Pezeshk et al., 2006). In general, 18F-FDG-PET or PET/CT would appear to have a 
complementary role to conventional staging procedures (Cook et al., 2010; as cited in Kleis et 
al., 2009, Kneisl et al., 2006 and Völker et al., 2007). After a diagnosis of a malignant primary 
bone lesion is made, the use of bone scintigraphy to define the extent of tumor before surgical 
resection is controversial: good correlation between increased bone tracer uptake and true 
anatomical extent that has been reported (Cook et al., 2010; as cited in Goldmann et al., 1975, 
McKillop et al., 1981, and Papanicolou et al., 1982), has not been supported by other studies 
(Chew & Hudson, 1982). These discrepancies may be due to peritumoral reactive changes 
overestimating extent or underestimations due to inability to detect marrow and soft-tissue 
involvement. For these reasons, MRI is the most accurate noninvasive assessment of tumor 
extent. On the other hand, several studies have reported the ability of bone scintigraphy to 
predict histological response to preoperative chemotherapy in patients with primary 
malignant bone tumors. Ozcan et al have reported a study of 27 patients with osteosarcoma, 
Ewing’s sarcoma, and malignant fibrous histiocytoma, which has displayed a reduction in 
hyperemia and extension as the most notable findings on three-phase bone scintigraphy. A 
reduction in tumor blood flow of 58.7% was found in 15 responding patients compared with 
19.9% in the nonresponders. A higher accuracy in assessing response was possible using all 
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the information from three-phase scintigraphy (88%), compared with static imaging alone 
(74%) where the blood flow and blood pool images showed a reduction in vascularity and 
extension. These are consisting features with the results published in previous studies (Cook 
et al., 2010; as cited in Knop et al., 1990, and Sommer et al., 1987). The sensitivity of 18F-FDG-
PET in staging primary bone tumors appears to vary between different tumor types and 
location of metastases. Spiral CT is the modality of choice for detection of relatively small 
lung metastases. Franzius et al compared the detection lung metastases of sarcoma by CT and 
18F-FDG-PET, showing a higher sensitivity for the former modality especially in lesions <9 
mm. 18F-FDG-PET may, however, assist in differentiating nonspecific lung nodules from 
metastases detected by CT in case of larger lung lesions, within the size range of PET 
resolution. 18F-FDG-PET may also identify unexpected extra pulmonary metastases. Serial 
18F-FDG-PET assessment of primary bone tumors (predominantly osteosarcomas, Ewing’s 
sarcomas, or both) is a good non-invasive method to predict pathologic neoadjuvant 
chemotherapy response (Cook et al., 2010; Even-Sapir, 2007). Another earlier study also 
showed a correlation with pathologic response but described high 18F-FDG uptake in 
granulation and/or fibrotic tissue and in the fibrous pseudocapsule of treated tumors (Cook 
et al., 2010; as cited in Jones et al., 1996).  
Multiple myeloma hardly triggers osteoblastic reaction and therefore scintigraphy is less 
sensitive than plain radiography and CT. FDG-PET indicates active myeloma and CT shows 
bone destruction. Therefore hybrid whole-body PET/CT is an excellent method to evaluate 
myeloma. Currently whole-body and spinal MRI and PET/CT are considered the imaging 
techniques of choice for initial evaluation and follow-up of these patients. Durie et al 
assessed the role of 18F-FDG-PET in 66 patients with multiple myeloma and monoclonal 
gammopathy of undetermined significance. Their results suggested that a positive 18F-FDG-
PET reliably indicates the presence of active myeloma, whereas a negative study strongly 
supports the diagnosis of monoclonal gammopathy of undetermined significance. 18F-FDG-
PET has also been reported to identify unexpected medullar and extramedullar sites of 
myelomatous disease not appreciated on X-ray, CT, or scintigraphy (Even-Sapir, 2007). In a 
recent report on 28 patients with multiple myeloma, 18F-FDG-PET/CT and MRI of the spine 
were shown to have complementary roles. Although the former modality detected more 
lesions, all of which were located outside the field of view of MRI, the latter modality was 
found superior for diagnosing an infiltrative pattern in the spine (Nanni et al., 2006). In 
another recent report, 18F-FDG-PET was found to be valuable in detecting infection in 
patients with multiple myeloma (Even-Sapir, 2007).  
Osteosarcoma represents only 0.1% of all tumors, but it is the second most frequent 
malignant primary bone tumor after myeloma. The diagnosis of osteosarcoma is based on 
characteristic histologic features in combination with typical radiographic findings. MRI of 
the entire suspected bone is performed to define the degree of penetration of the tumor 
surrounding soft tissue as well as to estimate the local tumor infiltration into bone marrow. 
Furthermore, CT of the chest and conventional bone scan are necessary for early detection of 
metastases. MRI and scintigraphy are also used to distinguish postoperative changes from 
residual or recurrent tumor tissue after local surgical treatment. Because osteosarcoma 
metastases usually incorporate bisphosphonates, bone scanning can be used for follow-up 
examinations to detect both osseous and nonosseous metastases. High-resolution CT has 
been shown to be superior to 18F-FDG-PET for detecting lung metastases. Data on the 
benefit of 18F-FDG-PET for detecting skeletal metastases in osteosarcoma patients are still 
very sparse, but successful detection of all sites of bone involvement by 18F-FDG-PET has 
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been reported recently (Even-Sapir, 2007; as cited in Franzius et al., 2002). Nevertheless, in 
children there may be an exception for primary staging, where there may be an indication 
for 18F-FDG-PET to detect intraosseous skip metastases in cases of unequivocal MRI 
findings, although no data are yet available to support this hypothesis. PET scans will not 
obviate the need for biopsy and tissue diagnosis in soft-tissue and bone masses, but it is 
remarkably helpful to guide biopsy. Non-PET–guided biopsy might miss the most 
biologically significant region, resulting in a false low pre-therapeutic tumor grading. 18F-
FDG-PET imaging data has shown reliability for prediction of tumor response to 
preoperative, neoadjuvant chemotherapy. On the other hand, for differentiation between 
benign residual mass lesions caused by post-therapeutic tissue changes and residual tumor 
tissue or local relapse, 18F-FDG PET is considered to be highly sensitive and more accurate 
than CT or MRI (Brenner et al., 2003). A high baseline uptake of 18F-FDG in osteosarcoma 
has been reported as showing an inverse correlation with prognostic indicators and is 
associated with a poor outcome with similar results for patients with high post-treatment 
FDG activity (Cook et al., 2010; as cited in Costelloe et al., 2009; Franzius et al., 2002). 
Ewing’s sarcoma is a highly malignant primary bone tumor that is being derived from red 
bone marrow. It accounts for approximately 5% of biopsy-analyzed bone tumors and 
approximately 33% of primary bone tumors. No single morphologic or functional imaging 
method provides findings for a specific diagnosis of Ewing’s sarcoma, but the results do 
contribute to tumor staging. Because the clinical symptoms of Ewing’s sarcoma are nonspecific 
and because they frequently suggest osteomyelitis, an initial conventional radiographic 
and/or MRI examination is performed. With static bone scintigraphy, Ewing’s sarcoma is 
usually depicted as a focal area of increased radionuclide activity. Whole-body bone scans can 
provide information about the primary lesion and depict skip lesions. Also, bone scintigraphy 
can be used to localize distant metastases during tumor staging. Three-phase dynamic bone 
scintigraphy can help in the assessment of treatment effects, with a reported accuracy of 88%. 
In cases that respond to treatment, a reduction of both flow and tracer uptake can be observed. 
18F-FDG-PET may help to detect lesions that are not shown on conventional bone scans. It is 
the most sensitive modality for therapeutic follow-up, and this modality can reveal early 
changes in tumor metabolism, which is an indicator of the therapeutic effect. 
Regarding the lymphomatous disease, primary skeletal involvement occurs in 3 to 5% of 
patients with non-Hodgkin’s lymphoma, and secondary bone involvement occurs in up to 
25% of patients. Moog et al have reported 18F-FDG-PET to be more sensitive and specific 
than Tc-99m-MDP bone scintigraphy for detection of osseous involvement by lymphoma. 
Early bone involvement may present as abnormal on 18F-FDG-PET with normal CT 
appearance, since detection of malignant bone involvement on CT depends on the presence 
of a considerable amount of bone destruction.  
9.3 Metastases 
Bone metastasis is the most common malignant bone tumor. It affects two thirds of cancer 
patients, and tumors that most often lead to metastases are breast, lung and prostate 
neoplasms. Bone involvement by cancer occurs most commonly by hematogenous spread, 
although tumor may occasionally extend directly from the soft tissue to the adjacent bone. 
The vast majority of bone metastases initiate as intramedullary lesions. The normal bone 
undergoes constant remodeling, maintaining a balance between osteoclastic (resorptive) and 
osteoblastic activity. As the metastatic lesion enlarges within the marrow, the surrounding 
bone undergoes osteoclastic and osteoblastic reactive changes. Based on the balance 
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between the osteoclastic and osteoblastic processes, the radiographic appearance of a bone 
metastasis may be lytic, sclerotic (blastic), or mixed. The osteoblastic component of the 
metastasis represents reaction of normal bone to the metastatic process. The incidence of 
lytic, blastic, and mixed types of bone metastases is different in various tumor types. Lytic 
lesions may be seen in almost all tumor types. Bone metastases of bladder, kidney, and 
thyroid cancer and lesions of multiple myeloma are invariably lytic. Blastic lesions are 
frequently seen in prostate and breast cancer, occasionally in lung, stomach, pancreas, and 
cervix carcinomas, and infrequently in colorectal cancer (Beheshti et al., 2009; Even-Sapir, 
2005). The most frequent distribution of metastasis in the human skeleton is usually 80% in 
the axial skeleton and ribs, 10% skull and 10% in long bones. Approximately 40% of patients 
with metastases have no pain at diagnosis (Diaz & De Haro, 2005). Symptoms occur mainly 
when the lesion increases in size, causing extensive bone destruction, which may lead to 
collapse or fracture, or in the presence of accompanying complications, such as spinal cord 
compression or nerve root invasion. 
Bone scan is the primary tool for screening or monitoring bone metastases due to its high 
sensitivity, versus plain radiography (Brown, 1993), and plays an integral part in tumor 
staging and management, since early detection of skeletal metastases optimizes 
management (Even-Sapir, 2005). Scintigraphic image of metastases is one or more high 
uptake foci in 98% of the cases, and the usual pattern consists of increased radiotracer 
deposition in areas of osteoblastic reparative activity in response to tumor osteolysis. The 
presence of multiple, randomly, distributed areas of increased uptake of varying size, shape, 
and intensity is highly suggestive of bone metastases, specially at sternum, scapula and ribs. 
Although multiple foci of increased activity may be encountered in other pathologic 
conditions, it is often possible to distinguish metastatic disease from other entities by 
analyzing the pattern of distribution of the abnormalities. Traumatic injury, in contrast to 
metastatic disease, generally manifests as discrete focal abnormalities of similar intensity. 
Multifocal rib trauma has a characteristic linear distribution. In patients with osteoporosis, 
the presence of kyphosis and/or an H-shaped sacral fracture suggests the correct diagnosis. 
In older patients, osteoarthritis and degenerative changes may manifest as areas of intense 
activity on radionuclide bone images. These changes can be distinguished from metastatic 
disease by virtue of their characteristic location (eg, knees, hands, wrists). Involvement of 
both sides of the joint is common in arthritis but unusual in malignant conditions. The 
remaining 2% is mild uptake foci owing to preponderance of osteolytic activity. The 
possibility of an artifact should be ruled out in cases of well-defined cold spot. In cases of 
wide-spread metastases, the radiopharmaceutical can be almost completely captured and it 
may lead to a superscan image, where kidney or bladder silhouettes are not initially seen by 
the delay in urinary excretion of radiotracer. A superscan may also be associated with 
metabolic bone disease but, in this case, the uptake is more uniform in appearance and extends 
into the distal appendicular skeleton. Intense calvarial uptake that is disproportionate to that 
in the remainder of the skeleton is another feature of a metabolic superscan. SPECT is reported 
to detect 20 to 50% more lesions in the spine compared with planar scintigraphy, and it 
increases both the sensitivity and specificity. The new hybrid system, SPECT with multislice 
CT, improves diagnostic accuracy (Dasgeb et al., 2007). The most common radiotracer is Tc-
99m-MDP but in patients with follicular thyroid carcinoma or in cases of neuroblastoma, 
iodine-131 (131I) and 123I-Metaiodobenzylguanidine (123I-MIBG) are more sensitive. 
Increased uptake of these radiotracers reflects the osteoblastic reaction of bone to the 
destruction of bone by the tumor cells, whereas increased 18F-FDG activity at the sites of bone 
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lesions on PET study represents active tumor itself. Bone scintigraphy is more sensitive than 
FDG-PET for detection of blastic/sclerotic lesion, whereas FDG-PET is more sensitive for lytic 
lesions and bone marrow disease. The latter has the additional ability to assess extraskeletal 
metastatic disease. Hybrid PET/CT imaging improves the specificity of FDG-PET for skeletal 
metastases (Dasgeb et al., 2007; as cited in Even-Sapir, 2005). An additional finding from 
scanning the peripheries, particularly in patients with bronchogenic carcinoma, may be the 
observation of hypertrophic osteoarthropathy secondary to cortical periostitis, that typically 
appears as symmetrical, nonuniform, irregular cortical uptake involving the long bones, most 
often seen in the femora, tibiae and wrists, and giving rise to the “tramline sign” 
(Gnanasegaran et al., 2009; Love et al., 2003; as cited in Ernstoff  & Meehan, 2000). In patients 
with bone metastases who have received chemotherapy, reparative osteoblastic reaction that 
occurs after this treatment may lead to the appearance of bone areas with intense uptake 
during the first 3 months (flare phenomenon). As healing progresses, uptake in the lesion 
disminishes and by 6 months it should generally be possible to differentiate response from 
progression (Love et al., 2003). 
18F-FDG-PET has become a routine imaging modality for staging and monitoring the 
response to therapy in patients with lymphoma. There are accumulating data indicating that 
18F-FDG-PET may detect early marrow infiltration and may add clinically relevant 
information when performed in patients with primary or secondary lymphomatous bone 
involvement. FDG-PET can detect early marrow infiltration and therefore is more sensitive 
than planar scintigraphy or CT for assessment of early skeletal involvement in lymphoma 
(Dasgeb et al., 2007). A pattern of heterogeneous patchy marrow activity should raise the 
suspicion of marrow involvement in an 18F-FDG-PET study prior to therapy, while a 
pattern of diffuse uptake, mainly in Hodgkin’s Lynphoma, is more commonly associated 
with reactive hematopoietic changes or myeloid hyperplasia (Even-Sapir, 2007).  
Metastatic disease occasionally manifests as a solitary abnormality, usually in the spine, 
although other causes such as fractures, avascular osteonecrosis, primary bone tumors and 
infections must be previously ruled out. The location and/or characteristics of the lesion 
may guide the diagnostic suspicion but, especially if it is a solitary lesion, it must be studied 
with other imaging techniques such as CT or/and MRI (Schneider, 2006). Approximately 
50% of cases in which scintigraphy detect a solitary focal uptake in a patient with a history 
of cancer, it is a metastasis. In patients with breast cancer, the sternum is a relatively 
common site to be affected often as a solitary lesion and probably results from local spread 
from the involved internal mammary lymph nodes. If a sternal lesion is situated distant 
from the manubriosternal junction, is irregular, asymmetric, or eccentric, then malignant 
involvement should be suspected. In a retrospective study of patients with breast cancer, 
3.1% presented with an isolated sternal lesion and 76% of these were found to represent 
metastatic disease (Gnanasegaran et al., 2009; as cited in Kwai et al., 1988). Vertebral body 
fractures have a characteristic appearance on bone scintigraphy, showing a horizontal linear 
pattern of increased tracer accumulation. However, it is usually not possible to differentiate 
fractures due to benign diseases, such as osteoporosis from malignant collapse. In such 
cases, further evaluation with MRI is often the most informative. However, multiple linear 
abnormalities of varying intensity favour a benign etiology with presumed osteoporotic 
fracture occurring at different time points. Also, a follow-up bone scan after a few months 
that shows reducing activity at a vertebral fracture site, suggests a benign cause and a 
healing fracture. SPECT technique improves the localization and characterization of the 
vertebral lesions, due to its ability to delineate the body, pedicles, and spinous process: 
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Lesions that extend from the vertebral body into the posterior vertebral elements or involve 
the pedicle are more likely to represent metastases than lesions confined to the facet joints, 
anterior vertebral body, or either side of a disc (Gnanasegaran et al., 2009). 
10. Osteoarthritis 
Osteoarthritis (OA) is the most prevalent chronic joint disease and it has the greatest health 
economic impact. Conventional radiography is still the first and most commonly used 
imaging technique for evaluation of a patient with a known or suspected diagnosis of OA 
(Guermazi, 2009). MRI is an appropriate tool for describing changes in cartilage volume and 
concomitant soft-tissue alterations. But for qualitative cartilage imaging, MRI has, to date, 
not been fully validated. Bone scan allows the differentiation of inflammatory from 
degenerative joint affections and may add information on the activity of the subchondral 
bone, which may develop to a prognostic marker of OA (Zacher et al., 2007). Another 
pronostic marker of slower progression that can help us deciding the most appropriate 
management is the imaging of the joints that show up as “cold” (Colamussi et al., 2004). 
Radionuclide joint imaging is more sensitive than clinical or radiographic techniques in 
detecting early joint involvement but usually it must be supplemented by other techniques 
to establish a specific diagnosis (Hoffer & Genant, 1976). 
Usefulness of molecular imaging for early diagnosis of OA is still a challenge. Cartilage 
damage in OA is being recharacterized as having an earlier dynamic phase, where cartilage 
damage is potentially reversible, followed by an irreversible pathologic phase that 
ultimately leads to joint pain and immobility (Hu & Du, 2009). The point at which cartilage 
damage is deemed irreversible has not been defined but probably depends on the size of the 
lesion, age of the patient, underlying cause, comorbid factors, activity level, use of joint 
stabilizers, genetic predisposition, and other factors. To detect early cartilage damage, 
molecular imaging research has focused on the identification of better ways to either 
visualize extracellular matrix depletion or measure events that are associated with cartilage 
damage, such as chondrocyte death and the elaboration of matrix-degrading enzymes. In 
OA, there is general acceptance that abnormal chondrocyte apoptosis is a pivotal event in 
the eventual destruction of articular cartilage (Biswal et al., 2007). A method for the study of 
cell death in living subjets is based on an endogenous protein, annexin V, whose function is 
not clearly understood but which is thought to play a role in coagulation (Biswald et al., 
2007; as cited in Reutelinsperger & Van Heerde, 1997). This protein has an extremely strong 
affinity for the cell membrane phospholipid phosphotidylserine, which is expressed to the 
outer surface of the cell membrane during the apoptotic cascade. The use of annexin V, 
labelled with either a radioisotope or a fluorescent marker, provides an excellent 
opportunity to image programmed cell death. To date, annexin V has been labelled with 
99mTc, iodine (125I, 124I, 123I), 111In, 11C, gallium (Ga-67, Ga-68), and 18F, making it 
appropriate for either SPECT or PET imaging (Biswald et al., 2007; as cited in Blankenberg, 
1998; Glaser, 2003; Lahorte, 2004; Russell, 2002; Zijlstra, 2003). However Annexin V imaging 
has yet to be applied to the assessment of human OA. Another event associated with 
cartilage damage is the elaboration of matrix-degrading enzymes. In OA damaged cartilage 
appears to activate hibernating proteases such as matrix metalloproteinases and cathepsins. 
Using a cathepsin B–sensitive near-infrared fluorescent probe, researchers have found 
significant amounts of signal arising from an arthritic knee compared with normal knees in 
an animal model of OA (Biswald et al., 2007; as cited in Lai, 2004). 
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11. Heterotopic ossification 
Heterotopic ossification (HO) is defined by the presence of bone in soft tissue where bone 
tissue normally does not exist, and it usually takes place around large joints (Medina et al., 
2008). Its etiology is unknown, but is frequently precipitated by trauma, spinal cord injury 
or central nervous system injury (Shebab et al., 2002). The incidence of HO varies widely 
between populations. The incidence after hip replacement ranges from 16% to 53%; among 
patients with spinal cord injury HO develops in 20-25% and in brain injury patients the 
incidence of HO ranges from 10 to 20% (Medina et al., 2008; as cited in Vanden & 
Vanderstraeten, 2005). Around 20% of the patients who have an HO will develop functional 
limitation and it will be severe in 8% to 10% (Medina et al., 2008; as cited in Buschbacher, 
1992; Subbarao, 1999). HO may closely mimic the presentation of cellulitis, osteomyelitis, or 
thrombophlebitis. HO can even be confused with some bone tumors such as osteosarcoma 
or osteochondroma. To resolve such diagnostic uncertainty and to prevent functional 
limitations, clinicians often request bone scanning and other imaging studies for patients at 
risk (Shebab et al., 2002). Radiography, MRI and CT have low sensibility in early stages of 
HO and three-phase bone scintigraphy (Fig. 7) is the most sensitive imaging modality 
during this period. It is also useful for its monitoring (Vanden & Vanderstraeten, 2005).  
 
 
Fig. 7. Bone Scanning: increased uptake around the left hip consistent with Heterotopic 
Ossification. 
First and second phases of three-phase bone scintigraphy are especially sensitive to detect 
incipient HO, which may be diagnosed 2.5 weeks after injury. Findings on the third phase 
may become positive approximately 1 week later. Radiographic studies do not show any 
change for at least 5- 8 weeks after initial injury (Shebab et al., 2002; as cited in Freed et al., 
1982; Orzel & Rudd, 1985). Activity on the delayed bone scans usually peaks in a few 
months and after that the intensity of HO activity progressively lessens and thus the uptake 
of the radiotracer on the scans, which return toward normal within 12 months. However, in 
some cases activity remains slightly elevated even though the underlying HO has become 
mature (Shebab et al., 2002; as cited in Tibone et al., 1978). During the course of HO, bone 
scans made on follow-up may show radiotracer uptake on third phase even after flow and 
blood-pool images have returned to normal. Serial bone scans have been used successfully 
to monitor the metabolic activity of HO and determine the appropriate time for surgical 
resection, if needed, and to predict postoperative recurrence (Shebab et al., 2002; as cited in 
Freed et al., 1982; Muheim et al., 1973; Rossier et al., 1973; Tanaka et al., 1977). For the 
differential diagnosis of osteomyelitis complementary imaging with gallium-67 citrate (for 
spinal infection) or indium-111-labeled autologous leukocytes (for the appendicular 
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skeleton) may be necessary, as commented in that section. Gallium-67 citrate uptake in HO 
is proportional to the uptake of 99m Tc-diphosphonates, in contrast to the relatively greater 
gallium-67 citrate uptake characteristic of osteomyelitis (Shebab et al., 2002). 
A diagnostic-treatment algorithm of heterotopic ossification has been proposed, and three-
phase bone scintigraphy has been recommended, after clinical signs and laboratory test, for 
its diagnosis in patients without HO but with high risk factor. If clinical signs and symptoms 
are present but initial radiographic studies are normal, bone scan should be repeated after 4-
6 weeks, and when scintigraphic studies have displayed the HO, it should be made every 
three months during the first year. Bone scan has also been proposed during the follow-up 
after HO removal to monitor possible recurrences (Medina et al., 2008). 
12. Fractures 
Following known injury, fractures are commonly demostrated by conventional radiography 
of most sites of trauma. In such circumstances bone scintigraphy has no major role, although 
unsuspected lesions may be identified. Acute fractures show increased perfusion on the 
radionuclide angiogram; intense, poorly marginated increased tracer accumulation 
representing relatively increased vascularity on the blood pool images; and intense poorly 
defined increased tracer accumulation on delayed images (Holder, 1993). 
12.1 Occult fractures 
Scintigraphy may be valuable in the diagnosis of occult fractures, which are true fractures 
not immediately obvious on clinical examination or plain radiography, and it is particularly 
useful to detect certain type of fractures that require urgent orthopedic treatment, such as 
femoral neck and intertrochanteric fractures, scaphoid fracture, and Lisfranc fracture. Occult 
femoral neck and intertrochanteric fractures are frequents in older females with continued 
hip pain following a fall. Shortly following the time of injury, there is an increase in 
perfusion to the fracture site which can be demonstrated during the rapid sequence flow 
study and blood pool phases of the so called three-phase bone scan. The time for first 
appearance of increased uptake on delayed 99mTc-diphosphonate images remains 
controversial, fluctuating between 24 hours and 2 weeks (Collier et al., 1993; as cited in 
Holder et al., 1990; Matin, 1979; Spitz, 1991). These problems are not encountered in the 
identification of scaphoid fracture which is readily visualized within 3 days of trauma. Bone 
scan demonstrates a focus of intense uptake usually centered in the scaphoid (Collier et al., 
1993; as cited in Patel et al., 1992; Tiel-van-Buul et al., 1992). High-resolution bone scan 
images obtained with the wrist first in a neutral position and then in ulnar deviation are 
used to localize the scintigraphic abnormality to the scaphoid. With ulnar deviation there is 
movement and rotation of the scaphoid relative to adjacent bony landmarks such as the 
radial styloid (Collier et al., 1993). Premature imaging withing 48 hours must be avoided, 
particularly as the osseous scintigraphic changes may be obscured by the diffuse uptake 
resulting from superficial hyperemia or traumatic sinovitis. Prolonged delay of this study 
may also result in increased uptake associated with disuse and thus, masking the fracture 
(Murray, 1998). Scintigraphy is therefore of considerable value in identifying this lesion 
before X-ray change appears, especially as difficulty may be encountered in radiological 
diagnosis even after 2-3 weeks (Murray, 1998). Difficulties in identifying the exact anatomic 
localization of a focus of uptake can be overcome by the technique of a combined display of 
the scan and the X-ray (Murray, 1998; as cited in Hawkes, 1991). Other occult fracture that  
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can require urgent treatment is Lisfranc fracture. This fracture presents a characteristic 
appearance on bone scan with a band of increased uptake extending across multiple 
tarsometatarsal joints, typically involving the first through fifth or the second through fifth 
tarsometatarsal joints (Collier et al., 1993; as cited in Fogelman & Collier, 1989). 
12.2 Stress fractures 
Stress fracture occurs when a bone breaks after being subjected to repeated tensile or 
compressive stresses, none of which would be large enough to cause individually the bone to 
fail, in a person who is not known to have an underlying disease that would be expected to 
cause abnormal bone fragility (De Weber, 2011).  The incidence of stress fractures is less than 1 
% in the general population. The reported incidence in athletic populations varies with the 
type of athlete. Among military recruits the incidence ranges from 1 to 31 %, among runners 13 
to 52 %, and among participants in collegiate team sports 1 to 8 % (De Weber, 2011; as cited in 
Bennel, 1997). In most instances, the individuals who suffer stress fractures have been 
engaging in vigorous activity to which they have not yet become conditioned. The failure to 
recognize the characteristic clinical and imaging findings of a stress fracture and the continued 
excessive exercise by the athlete will occasionally lead to a complete fracture (Collier et al, 
1993). Imaging is needed when high risk stress fractures are suspected or a definitive diagnosis 
is necessary. The sites at high risk complications are the pars interarticularis of the lumbar 
spine, femoral head, superior side of the femoral neck, patella, anterior cortex of the tibia, 
medial malleolus, talus, tarsal navicular, proximal fifth metatarsal, great toe sesamoids, and 
the base of the second metatarsal bone (De Weber, 2011). 
 
º 
Fig. 8. Scintigraphy: localized uptake in tibial metaphysis and both internal femoral 
condyles. 
Three-phase bone scan has traditionally been used for diagnosis of stress fractures because it 
can show evidence of stress fracture within 2 to 3 days of injury and has high sensitivity. Acute 
stress fractures appear as discrete, localized, sometimes linear areas of increased uptake on all 
three phases (angiographic, soft tissue, and delayed phases) of a Tc-99m-MDP bone scan (Fig. 
8). However, the specificity of bone scan is low. Approximately 40 % of positive findings occur 
at asymptomatic sites (De Weber, 2011; as cited in Bennell et al., 1999). Bone scan can  
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also be falsely positive with shin splints, despite shin splints are typically positive only 
during the delayed phase of the scan (De Weber, 2011; as cited in Deutsch, 1997). Areas of 
increased uptake may represent subclinical sites of bone remodeling or stress reactions. 
Increased uptake can also appear in the setting of bone tumors, osteomyelitis, or avascular 
necrosis. Although rare, there are reports of false-negative bone scans (De Weber, 2011; as 
cited in Gaeta et al., 2005; Spitz & Newberg, 2002). Because of these limitations, MRI is 
supplanting bone scan as the diagnostic tool of choice when plain radiographs are negative 
and confirmation of suspected stress fracture is needed.  
12.3 Insufficiency fractures 
Insufficiency fracture occurs when the mechanical strength of a bone is reduced to the point 
that a stress which would not fracture a healthy bone breaks the weak one (De Weber, 2011). 
Most commonly postmenopausal osteoporosis is the cause for insufficiency fractures. 
Additional conditions affecting bone turnover include osteomalacia, chronic renal failure, 
and high-dose corticosteroid therapy (Krestan et al., 2011). Insufficiency fractures occur 
most commonly in the pelvis, including the sacrum, followed by the proximal femur and the 
vertebral bodies, in particular in the lower thoracic and the lumbar spine. Other sites 
frequently affected by insufficiency fractures are the tibia, fibula, and calcaneus (Krestan & 
Hojreh, 2009; as cited in Soubrier, 2003). Radiographs are the basic modality used for 
screening of insufficiency fractures, but depending on the location of the fractures, 
sensitivity is limited. Thus, MRI and CT are both standard techniques when insufficiency 
fracture is suspected and initial radiological studies are negative. MRI is a very sensitive tool 
to visualize bone marrow abnormalities associated with insufficiency fractures and allows 
differentiation of benign versus malignant fractures. Multidetector CT depicts subtle 
fracture lines allowing direct visualization of cortical and trabecular bone (Krestan et al., 
2011). Bone scintigraphy is also highly sensitive and specific when typical pattern of 
abnormality is present. One of those typical patterns of uptake is the classical H (‘Honda’ 
sign) or butterfly-shaped appearance in sacral insufficiency fracture in the elderly 
osteoporotic patient without definite trauma history. The vertical limbs of the H lie within 
the sacral ala, parallel to the sacroiliac joints, while the transverse limb of the H extends 
across the sacral body. Other sacral variant uptake patterns occur frequently and include the 
unilateral ala, incomplete H and horizontal linear dot patterns. Iliac fractures are seen as 
linear areas of increased radionuclide uptake. Pubic and supra-acetabular fractures produce 
areas of linear or focal uptake. Concomitant findings of two or more areas of increased 
uptake in the sacrum and at another pelvic site are considered diagnostic of insufficiency 
fractures of the pelvis. If a typical pattern of abnormality is not present, the radionuclide 
bone scan is much less specific. If abnormal or incomplete patterns of uptake are observed, 
findings may be mistaken for malignancy and other etiologies. PET–CT with hybrid-
scanners has been the upcoming modality for the differentiation of benign from malignant 
fractures (Krestan et al., 2011). 
12.4 Pathologic fractures 
This type of fractures is due to a localized loss of strength secondary to an underlying 
disease process. Examples of pathologic fractures include those that occur at sites of bone 
tumors (primary or metastatic), bone cysts, and infections (De Weber, 2011). About 10% of 
patients with known bone metastases will sustain a fracture. Most patients with high-risk 
conditions for bone metastasis are followed serially with bone scan to detect occult 
www.intechopen.com
 
12 Chapters on Nuclear Medicine 
 
124 
metastasis. In general, lytic lesions are considered more prone to fracture than blastic ones. 
In the spine, CT or MRI are both indicated to quantify the extent of tumor infiltration, 
including any extension into the spinal cord and are useful in distinguishing osteoporotic 
vertebral collapse from pathologic fracture.  
12.5 Non-union fractures 
In the setting of impaired fracture healing we can distinguish three complications: the 
delayed union, non-union and pseudoartrhosis. Delayed union describes the situation 
where there are distinct clinical and radiological signs of prolonged fracture healing time 
(Panagiotis, 2005). Scintigrams demonstrate intense tracer concentration at the fracture site, 
as does a fracture undergoing normal or non-union. Therefore, differentiation of a normal or 
delayed union from nonunited fracture may not be possible by scintigram alone. Clinical 
findings along with roentgenograms are usually adequate to distinguish delayed healing 
from nonhealing (Desai et al., 1980). Non-union fracture is defined as the cessation of all 
reparative processes of healing without bone union 6 to 8 months following the fracture or 
by the absence of progressive repair that has not been observed radiographically between 
the third to sixth months following a fracture (Panagiotis, 2005). Two main types of non-
union fractures are differentiated according to the viability of the ends of the fragments 
(Frölke& Patka, 2007; as cited in Weber & Cech, 1976): Avascular non-union and 
hypervascular non-union. In the first type the ends of the fragments are avascular or 
atrophic, inert and incapable of biologic reaction, and therefore bone scintigraphies indicate 
a poor blood supply at the edges of the fragments (Frölke& Patka, 2007). On delayed images 
atrophic non-union rim is seen as a photon deficient band between fracture ends (Holder, 
1993). The main problem in this type is the poor quality of the bone ends and the 
significantly diminished potential for repair (Gelalis et al., 2011). In the second type the rims 
of the fragment are hypervascular or hypertrophic and are capable of biological reaction. 
Bone scintigraphy in the latter indicates a rich blood supply in the ends of the fragments 
(Frölke& Patka, 2007). The main problem in this type is inadequate fracture stability or 
reduction. The third complication, pseudoarthrosis, is a non-union fracture which may take 
years to develop and may occur without clinical symptoms. It is characterised by the 
formation of a false joint where a fibrocartilaginous cavity is lined with synovium producing 
synovial fluid (Panagiotis, 2005; as cited in McKee, 2000). Scans using Tc-99m-MDP show 
the presence of a synovial pseudoarthrosis (Csongradi & Maloney, 1989; as cited in Esterhai 
et al., 1984). Two types can be distinguished as in the non-union fractures: atrophic and 
hypertrophic pseudoarthrosis. The first one is characterized in the scintigraphy by the 
absence of peripheral accumulation in contrast with the intense uptake surrounding a 
hypertrophic pseudoarthrosis. Those finding in the bone scan are highly suspect for 
pseudoartrhosis after 12 months. The use of SPECT with bone scanning enhances the 
sensitivity and specificity, especially in the pseudoarthrosis of the spine after a lumbar 
spinal fusion (Collier et al., 1993; Lee & Worsley, 2006). SPECT identifies a more focal area of 
intense activity within the area of increased accumulation at the fusion site (Murray, 1998). 
Some authors have used radionuclide scans to determine whether the fracture has the 
biologic ability to respond to a specific therapy such as electrical stimulation. With mature 
nonunions, radionuclide scans can identify large hypovascular areas that have no potential 
for healing. In such cases, operative intervention is needed. In a case of nonunion, the 
possibility of infection must be considered. An increase in activity at the fracture site on the 
radionuclide scan is consistent with both bony healing and infection. Infection at the 
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fracture site can also be a cause of persistent pain and contribute to the non-union 
(Csongradi & Maloney, 1989). Gallium scan is indicative of infection if 67Ga uptake exceeds 
99mTc uptake on the bone scan. The most specific tracers for infection however are 
leukocytes labelled with indium-111 or 99mTc (Schelstraete et al., 1992). 
13. Technical aspects and applications of bone scintigraphy in pediatric 
populations 
13.1 Technical aspects of bone scintigraphy in pediatric populations 
Technical considerations concerning care of the child, immobilization, dosing of 
radiopharmaceuticals, and instrumentation are of major importance in pediatric nuclear 
medicine. It is routine in many dedicated pediatric nuclear medicine departments to allow 
parents or siblings to remain in the imaging room to provide a sense of security and safety 
for the child. Similarly, the patient is allowed to hold a favorite toy or a prized possession 
and parents are instructed to bring such items with them for the test. Children are often 
most worried about the needle required for the injection. Many nuclear medicine 
departments now routinely use the application of topical anesthetic creams as part of the 
preparation for the examination (Nadel & Stilwell, 2001). Immobilization techniques to gain 
patient support in pediatric studies can vary from wrapping the patient to the use of 
sedation and general anesthesia. For neonates to age 2, it may suffice to hold the patient in 
place, deprive sleep, and feed the child while on the imaging table. Papoose techniques for 
bundling and entertainment including television, movies, music, or stories can be used to 
immobilize children older than 4 to 5 years of age. The cooperation of an older child can 
often be obtained if the procedure is carefully explained to them and their parents. Children 
between the ages of 2 and 5, or who are mentally retarded, or have severe attention deficit 
problems, are more likely to require sedation (Nadel & Stilwell, 2001). Guidelines from the 
American College of Radiology and the American Academy of Pediatrics can help in 
developing an appropriate institutional sedation protocol (Shammas, 2009; as cited in 
Gilday, 2003).  
The correct dosing for administration of radiopharmaceuticals to children is available in 
standard pediatric nuclear medicine texts and can be based on either body surface area or 
the weight of the child relative to adult dosage (Nadel & Stilwell, 2001; as cited in Miller & 
Gelfand, 1994; Treves, 1995). 99mTc- MDP is the most commonly used radiopharmaceutical 
for bone scintigraphy. Scanning is usually performed as a three-phase bone scan with 
immediate blood flow and blood pool imaging of the site of symptoms obtained after 
injection, followed by delayed imaging 1.5 to 2 hours later. It is important that the children 
are well hydrated to have optimum visualization. Other radiopharmaceuticals are also 
useful in the evaluation of musculoskeletal disease, such as 67Ga citrate or labelled 
leukocytes using indium-111 or 99mTc for musculoskeletal infection or a bone marrow scan 
using a 99mTc-sulfur colloid for bone marrow infarction, particularly in sickle cell disease 
(Shammas, 2009; as cited in Connolly et al., 2007; Gilday, 2003; Nadel & Stilwell, 2001). 18F-
FDG is the most common radiopharmaceutical used for PET or PET/CT. 18F-FDG 
accumulation occurs in inflammation and infection (Shammas, 2009; as cited in Love et al., 
2005; Zhuang & Alavi, 2002). Imaging of inflammation with 18F-FDG PET relies on the fact 
that infiltrated granulocytes and tissue macrophages use glucose as an energy source. When 
they are activated in inflammation, metabolism and thus FDG uptake increases (Shammas, 
2009; as cited in Kubota et al., 1992).  
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Proper positioning is important in pediatrics particularly in young infants, and although 
children are smaller, it does not imply that more of a child can be imaged on a single 
scintigraphic view. In fact, examinations take longer in children and infants because of the 
requirement of joint-to-joint images for detailed assessment. Although the new gamma 
camera systems often allow whole-body passes it is often necessary to supplement these 
images with magnified spot views or even pinhole imaging. Image magnification either 
with camera zoom, computer magnification, or collimation is essential when performing 
scintigraphic examinations in children. Magnification is either optical with collimation or 
electronic. Optical magnification uses either a pinhole or converging collimator, enlarges the 
image, and improves overall system resolution. Electronic magnification makes the image 
bigger without altering overall system resolution. The capability for SPECT imaging is 
essential in pediatric scintigraphy. SPECT allows for improved image contrast and hence 
improved diagnostic accuracy. It is helpful in localizing and further defining most 
musculoskeletal abnormalities to include the extremities and is essential when assessing a 
child with the clinical problem of back pain. Multiple head detector gamma camera systems 
are becoming more available in pediatric centers. The advantages of these systems include 
increased resolution and sensitivity and decreased time of examination in a child. 
Correlative imaging is essential to state of the art practice of pediatric nuclear medicine. 
Computer multimodality image fusion programs are becoming available and more 
sophisticated. They allow comparison of different isotope scintigraphic studies or serial 
studies in the same patient or comparison of scintigraphy with other imaging modalities, 
such as CT, MR imaging, and PET for better correlation of anatomy and function. New 
combined gamma camera and CT devices allowing direct anatomic and physiologic 
correlation are also being manufactured and will have further impact on the care of the 
pediatric patient. 
The normal distribution in a pediatric bone scan may differ from adults (Shammas, 2009; as 
cited in Nadel, 2007). In children there is high physeal and apophyseal uptake due to their 
rich blood supply and active enchondral ossification. Absence of uptake in nonossified 
cartilaginous structures should not be mis- taken for avascular necrosis. Regions where this 
may be of concern in younger children include the femoral capital epiphysis, patella, and 
navicular bone. Before ossification, the ischiopubic synchondrosis appears as a discontinuity 
of the inferior pubic ramus. During ossification, increased uptake in ischiopubic 
synchondroses is a common normal variant and should not be misinterpreted as a 
pathological lesion (Shammas, 2009). 
13.2 Applications of bone scintigraphy in pediatric populations 
13.2.1 Infections 
Acute osteomyelitis is a common pediatric disease that mostly affects children under 5 years 
old. It usually is the result of hematogenous spread of infection due to the rich vascular 
supply of the growing skeleton. Typically, bone scan become positive 24 to 72 hours after 
the onset of infection, while plain films do not manifest evidence of infection until 3 to 4 
weeks after. Therefore, three-phase bone scintigraphy is the most sensitive imaging 
modality for early diagnosis. The sensitivity of a three-phase bone scan has been estimated 
as 94% with a specificity of 95% (Shammas, 2009; as cited in Schauwecker, 1992). Ideally, 
scintigraphic imaging should be obtained before joint aspiration, and a delayed whole-body 
scan on skeletal phase should be obtained because osteomyelitis in childhood can be 
multifocal or present with referred pain. In addition, malignant disease such as leukemia  
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and sarcoma may mimic acute osteomyelitis (Shammas, 2009; as cited in Connolly et al., 
2007; Ma et al., 2007). All three phases of the bone scan show focally high uptake in the 
affected bone. Occasionally, the affected bone in children shows low uptake or a photopenic 
defect (cold osteomyelitis) (Shammas, 2009; as cited in Pennington, 1999). This is most likely 
due to reduced tracer delivery by increased intraosseous pressure from inflammation, 
oedema, and joint effusion (Shammas, 2009). Cellulitis may be differentiated from 
osteomyelitis because the former typically demonstrates diffuse increased activity in the soft 
tissues on the first two phases, without focal osseous abnormality on the third phase 
(Shammas, 2009; as cited in Wegener & Alavi, 1991). Although chronic recurrent multifocal 
osteomyelitis (CRMO) and acute osteomyelitis share a common histopathologic feature, 
namely chronic inflammation, they are different in important ways (Nadel & Stilwell, 2001). 
CRMO occurs most frequently in the latter half of the first decade and the first half of the 
second decade of life, and it is more common in girls, differently from acute osteomyelitis 
that occurs in children under 5 years old (Shammas, 2009). A predisposing cause is not 
found for CRMO in contrast to conventional osteomyelitis (Nadel & Stilwell, 2001). Bone 
scintigraphy is helpful in identifying the multifocal bone lesions and characteristically 
displays high uptake in both symptomatic and asymptomatic lesions (Shammas, 2009, as 
cited in Connolly, 2007). Other infection typical of children under 3 years of age is septic 
arthritis. Monoarticular involvement is the most common pattern. The more affected joints 
are the knees and the hips. As in the osteomyelitis, there is an increased uptake on all three 
phases of three-phase bone scan, but in septic arthritis there is a symmetric uptake in both 
sides of the joint (Diaz& De Haro, 2005). Transient synovitis is the most common condition 
that mimics septic arthritis. In this case, three-phase bone scan may be normal or may show 
diffuse increased activity on the first two phases. Delayed images may displa periarticular 
increased activity in the affected joint (Shammas, 2009). 
13.2.2 Legg-Calve Perthe disease 
Legg-Calve Perthes disease is an idiopathic ischemic necrosis of the femoral head that 
occurs characteristically in children between 5 to 8 years. Bone scintigraphy is more 
sensitive than radiography for early diagnosis, and comparable to MRI (Shammas, 2009; as 
cited in Ma et al., 2007). Studies performed early after the onset of clinical symptoms show 
absence of activity in the capital femoral epiphysis and it may precede radiographic changes 
(Shammas, 2009; as cited Connolly & Treves, 1998). Later scans may demonstrate increased 
activity due to revascularization and remodeling. Bone scintigraphy has also a pronostic 
value and can be used in routine management to identify patients at high risk for a poor 
outcome (Shammas, 2009; as cited in Comte et al., 2003): Persistent absence of bone uptake 
in the proximal femoral epiphysis after 5 months or metaphyseal hyperactivity is highly 
correlated with more severe disease and a poorer prognosis. The early formation of a lateral 
column of tracer uptake in the capital femoral epiphysis, even before radiography, is 
associated with a good prognosis due to early revascularization (Shammas, 2009; as cited in 
Conway, 1993 and Tsao et al., 1997). 
13.2.3 Slipped capital femoral epiphysis 
Slipped capital femoral epiphysis is characterized by a displacement of the capital femoral 
epiphysis from the femoral neck through the physeal plate with medial and posterior 
rotation of the epiphysismost commonly in the adolescence. Bone scintigraphy is useful for 
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assessing the vascularity of the femoral head. In the absence of avascular necrosis, the bone 
scan findings in slipped capital femoral epiphysis are nonspecific and consist of mildly 
increased activity with widening and blurring of the growth plate activity (Shammas, 2009; 
as cited in Connolly et al., 2006, 2007). 
13.2.4 Sickle cell disease 
Sickle cell disease is the most common hereditary blood disorders. It occurs almost 
exclusively among black americans and black africans, related with the presence of a 
mutated form of hemoglobin, hemoglobin S. Bone and joint problems are the most common 
manifestations. Distinguishing sickle cell crisis with possible bone marrow infartion from 
osteomyelitis is a challenge (Shammas, 2009; as cited in Connolly et al., 2007). Bone marrow 
scan with 99mTc-sulfur colloid plus conventional bone scan may be used in the evaluation 
of sickle cell disease, but it should be done within the first 7 days after the pain onset to be 
helpful in the differential diagnosis (Shammas, 2009). If the bone marrow scan is abnormal 
at the site of pain, followed by normal or decreased uptake on conventional bone scan, 
infarction is the likely diagnosis. Increased uptake in blood pool and delayed images on 
conventional bone scan is more suggestive of osteomyelitis (Shammas, 2009; as cited in 
Gilday, 2003).  
13.2.5 Reflex sympathetic dystrophy 
Reflex sympathetic dystrophy has also been described elsewhere in this chapter. The typical 
findings on three-phase bone scan are hyperemia on the first two phases with intense 
periarticular activity in the affected extremity. In children, a cold variant has been reported, 
which is characterized by decreased activity in the three phases of the scintigraphy in the 
affected limb, compared with the nonaffected limb (Shammas, 2009; as cited in Nadel, 2007). 
13.2.6 Fractures 
The occult fracture more common in children is the Toddler’s fracture, which is a spiral or 
oblique fracture that can occur from pelvis to feet but mostly involves the tibia (Shammas, 
2009). Radiographic findings are often subtle and fractures may not be apparent, for that 
reason bone scan is a valuable tool for detecting this injury. Scintigraphy shows diffuse 
increased uptake in the tibial diaphysis or the bone affected. A linear or spiral pattern of 
high uptake may be seen in some children (Shammas, 2009; as cited in Connolly et al., 2006; 
Gilday 2003). 
Among stress fractures, spondylolysis is the more important in children with back pain, 
which represent a stress fracture of the pars interarticularis of the vertebra, commonly in the 
lower lumbar spine secondary to repetitive minor trauma such as hyperextension 
(Shammas, 2009). Clinical signs and symptons and radiographies are normally used for the 
diagnosis. A bone scan or a MRI may be necessary to determine if the spondylolysis is active 
or inactive. Bone scintigraphy shows little or no abnormality on blood pool images, but it 
typically demonstrates focally high uptake in the region of the pars interarticularis on 
delayed images. SPECT imaging is more sensitive than planar studies and detects 
abnormalities in about a third of individuals with normal planar examinations and so, it is 
recommended in the evaluation of low back pain in young athletes (Shammas, 2009; as cited 
in Sty, 1993). 
Scintigraphy has also an important role to provide a quick assessment for defining and 
characterizing the extent and severity of trauma in the setting of child abuse, complementary 
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to other radiologic investigations. Its major advantage is the increased sensitivity in detecting 
evidence of soft-tissue and bone trauma (25%to 50%), and in the documentation of specific and 
characteristic sites of abuse, such as in the ribs or the diaphyses of the extremities (Nadel & 
Stilwell, 2001; as cited in Conway et al., 1993, Sty & Wells, 1994). 
13.2.7 Primary bone tumors in childhood 
Benign bone tumors are by far the most common type of tumors that grow within the 
skeleton. Nonossifying fibromas, osteochondromas and simple bone cysts are the types 
most often found in children and teenagers. Children between the ages of 6 and 12 are the 
most likely to develop benign bone tumors, although the tumors sometimes show up in 
children as young as age 2. Exostosis tumors are slightly more common in boys than girls. 
Nonossifying fibroma usually is in the actively growing sections of long bones such as the 
thighbone (femur). Exostosis (osteochondroma) contains both bone and cartilage and 
usually grows in the thighbone, the shinbone (tibia) or the bone in the upper arm (humerus). 
Unicameral (simple) bone cysts are holes in the bone that fill with fluid and tissue. They 
usually occur in the bone in the upper arm or in the upper part of the thighbone. In some 
cases, a benign bone tumor can cause problems while it grows. It can weaken the child’s 
bone and make it more likely that the bone will break. Tumors also can press on nerves and 
cause pain. In cases like these, surgery may be necessary. Malignant primary bone 
tumors make up 5% of childhood malignancies, and osteosarcoma is the most commonly 
isolated malignant bone tumor in children, followed by Ewing's sarcoma. These bone 
neoplasms usually begin during childhood and adolescence, when bones are growing 
quickly and they often are taking part in sports and other physical activities. Langerhans cell 
histiocytosis is also more common in the pediatric population. A smaller number of patients 
have other diagnosis such as malignant fibrous histiocytoma, angiosarcoma and 
chondrosarcoma, but these conditions are very rare in paediatric population. The 
use of nuclear medicine techniques in the diagnosis, staging and monitoring of the different 
bone tumors has been detailed in a previous section of this chapter. FDG-PET has become to 
be one of the best tools for the baseline evaluation and follow-up, although some benign 
bone lesions may show high 18F-FDG accumulation, equivalent to osteosarcomas. Despite 
this, 18F-FDG-PET has a high specificity for excluding malignant bone tumors (Cook et al., 
2010). FDG- PET has been shown to help determine the presence and extent of sarcomas and 
even may allow the noninvasive estimation of the histologic grade of some tumors, although 
the biopsy remains necessary. This technique allows targeted biopsies, which can reduce the 
likelihood of underestimation of tumor grade and inadequate therapy. Furthermore, 18F-
FDG-PET is useful in the pediatric population for detection of skip metastases in cases of 
equivocal MRI findings (Even-Sapir, 2007). 
14. Therapeutic alternatives with radionuclides: Radiosynoviorthesis  
In the treatment of inflammatory rheumatic diseases with chronic course, operative and 
respectively arthroscopic synovectomy on the one hand and synoviorthesis on the other 
hand come into question. Synoviorthesis by corticosteroids has a very large indication if the 
corresponding measures of precaution are heeded. Chemical synoviorthesis, mainly by 
osmium tetroxide, is applied above all in exudative inflammatory diseases, whereas 
radiosynoviorthesis with the nuclides used at present is mainly applied in proliferative 
diseases. The cytotoxic effects intrinsic to the beta radiation emission from some 
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radionuclides have been exploited by nuclear medicine and, as well as treating several 
forms of neoplasia, this method can also be used to treat a number of benign articular 
pathologies in the field of rheumatology. Carry out a ‘radiosynovectomy’ procedure is 
possible after intra-articular administration of suitable radiopharmaceuticals. The direct 
irradiation of the synovial membrane can produce a therapeutic effect on persistent 
synovitis that is resistant to traditional drug treatment. The radiopharmaceuticals that have 
been used to date for radiosynovectomy are made up of small colloidal particles labelled to 
ǃ-emitting isotopes (yttrium-90, rhenium-186, erbium-169, samarium-153). These 
compounds release their radiation energy within a radius of a few millimetres from the 
uptake sites. These substances are phagocytized by synoviocytes localised in relation to the 
synovia and it creates a radiation source that can act locally and reduce inflammatory and 
proliferative elements (Colamussi et al., 2004; as cited in Gumpel et al., 1975). The 
availability of new radiopharmaceuticals, created by replacing the colloid vector with 
hydroxyapatite crystals, has allowed the main undesired effect of these substances 
(radiation to other organs such as drainage lymph nodes, liver, spleen and bone marrow, 
due to the passage of the radio compound from the articular cavity to the lymphatic and 
then to the blood flow systems) to be avoided (Clunie et al., 1996). In the absence of side 
effect, this technique of low cost may be useful, not only in the treatment of advanced stage 
and drug-resistant arthropathies, but also to manage pain and improve articular function in 
the first stages of rheumatoid arthritis (Colamussi et al., 2004; as cited in Uyeo et al., 1978). A 
fundamental element to the success of radiosynovectomy therapy is that treatment is started 
early in the disease’s history. This is because while radiation therapy can successfully 
control proliferation of the inflamed synovial membrane, it is not effective in joints that have 
suffered advanced osteo-cartilage damage and where the synovitic component is virtually 
non-existent (Franssen et al., 1989). Cases reported would further suggest its use in a wider 
spectrum of rheumatic disorders ranging from spondylitis to Paget’s disease and from 
hæmophiliac synovitis to pigmented villonodular synovitis. Nevertheless, despite abundant 
anecdotal evidence of its efficacy, there is a paucity of controlled trials and those that have 
been done have produced conflicting results (Dos Santos et al., 2009, 2011) and/or have 
been of insufficient sample size. Two meta-analyses have been published. The first one 
(Jones,  1993) was made in order to assess the evidence on yttrium-90 therapy for chronic 
synovitis of the knee. It found out that Yttrium was superior to placebo (OR 2.42, 95% CI 
1.02-5.73), although possible publication bias limited the interpretation of this result. 
Yttrium was not superior to triamcinolone (OR 1.89, 95% CI 0.81-10.55) or other active 
modalities (OR 1.04, 95% CI 0.72-1.52). The second one and most recent (Van der Zant et al., 
2009) has been published with the objective to perform a systemic review and meta-analysis 
on the effectiveness of radiosynoviorthesis. It has shown high success rates of 
radiosynoviorthesis, but differences in effect with glucocorticoid injection are less evident, 
although there is marked heterogeneity in study design of a small number of comparative 
studies. Therefore the efficacy of radiosynovectomy alone or in combination with steroid 
therapy must be assessed by other sufficiently powered randomised controlled studies.  
15. Conclusion  
Nuclear medicine techniques supply physiological information that is complementary to 
that provided by radiological techniques and can play a fundamental role not only for the 
examination and treatment of articular disorders but also in overall patient evaluation.  
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Though scintigraphical examination is ideal in the early stages of diseases, it also plays a 
complementary role to radiographical investigations in more advanced disease stages. An 
assessment as complete as possible which includes different complementary studies must be 
performed to achieve the best diagnostic and prognostic accuracy. In this context, 
conventional scintigraphy is still a major test in a limited number of rheumatological 
diseases such as Paget, reflex sympathetic dystrophy and osteonecrosis, and can be a useful 
complementary study in other diseases. New molecular imaging tools for the evaluation of 
musculoskeletal diseases are now available and these particular tools will advance the 
understanding and management of several chronic musculoskeletal diseases. In the next 
decade, PET/CT and SPECT/CT will be the major workhorses for molecular imaging, with 
the advantage that PET-based technologies have high sensitivity and the ability to use 
biologic molecules that can be radiolabelled.  
Despite the important role of the anatomic imaging techniques in the evaluation of primary 
bone tumors and metastases, radionuclide imaging techniques have all been used in the 
assessment of these disorders. PET and hybrid PET/CT imaging are becoming the most 
important modalities in this field.  
Β-radiation emission from some radionuclides has been exploited by nuclear medicine and 
has been used to treat benign joint pathologies, as well as treating several forms of 
neoplasia. It is of interest in the field of rheumatology, since it is as a safe procedure and, 
after intra-articular administration of suitable radiopharmaceuticals, is able to control 
proliferation of the inflamed synovial membrane in the treatment of chronic arthropathies, 
particularly in the initial stages of the disease. 
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